













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given. 
 
 
An investigation into theory of mind in individuals with 
multiple sclerosis: 
 
A systematic review of the psychometric properties of the theory of 
mind measures used in multiple sclerosis 
and 
Psychological, interpersonal and social functioning in multiple 







Rachel Gibson  
 
Doctorate in Clinical Psychology  







Firstly, I would like to give my sincerest thanks to my academic supervisors Clara Calia and 
Emily Newman. Clara, I would like to thank for her timely feedback, continuous positivity and 
encouragement. Emily, I wish to thank for her meticulous attention to detail, for keeping me 
on track and calm when challenges arose. My thanks also go to Alan Harper for his support in 
refining my research topic and his interest and support throughout the project. 
 
I wish to thank Debbie McCallion and all the staff at the Anne Rowling Clinic for their support 
with recruitment. Then, there are all the participants who offered their time to take part in 
this thesis. It was a pleasure to meet and learn from them all. Without them, this thesis would 
not have been possible. Thank you. 
 
Finally, I send my thanks to my wonderful friends and family. Especially, to my mum for her 
continued interest and listening ear- even when the topic made little sense to her! To my 
brother Neil for his statistical advice, proof reading and for sending me tea! Sami for co-rating 
my systematic review papers and to Kat, for going through this with me, our daily calls on the 






Table of Contents 
A systematic review of the psychometric properties of the theory of mind measures used in 
multiple sclerosis 1 
Acknowledgements 2 
Thesis Abstract 6 
A systematic review of the psychometric properties of the theory of mind measures used in 




Search Strategy 12 
Inclusion and Exclusion Criteria 12 
Study Selection 13 
Data Extraction 14 
Quality Evaluation/ Assessment 14 
Results 17 
What measures have been used to measure Theory of Mind in individuals with Multiple Sclerosis? 17 
Baron-Cohen Adult Eyes Test (Baron-Cohen et al., 2001) 17 
Baron-Cohen Adult Faces Test (Baron-Cohen, Wheelwright, & Jolliffe, 1997) 17 
Bordeaux Social Cognition Assessment Protocol (Etchepare et al., 2014) 18 
Conversation and Insinuations (Ouellet et al., 2010) 18 
Emotion Attribution Task (Blair et al., 1995) 18 
False Belief Tasks (Baron-Cohen et al., 1985; Rowe, Bullock, Polkey, & Morris, 2001) 18 
Faux Pas (Baron-Cohen, O’Riordan, Stone, Jones, & Plaisted, 1999; Stone et al., 1998) 19 
Faux Pas- Adapted (Henry et al, 2011, 2017) 19 
Genova Social Cognition Scale (Martory et al., 2015) 20 
Mini Social Cognition and Emotional Assessment (Bertoux et al., 2012, 2014) 20 
Movie for the Assessment of Social Cognition (Dziobek et al., 2006) 20 
Strange Stories (Happé, 1994) 20 
Strange Stories- Adapted (Isernia et al., 2019; Raimo et al., 2017) 21 
The Awareness of Social Inferences Test (TASIT; McDonald et al., 2006; McDonald, Flanagan, Martin, 
& Saunders, 2004; McDonald, Flanagan, Rollins, & Kinch, 2003) 21 
The Theory of Mind Sequencing Task (Brüne, 2003) 21 
TOM Video Task (Sullivan & Ruffman, 2004) 22 
Virtual Assessment of Mentalising Ability (Canty et al., 2017) 22 
What are the psychometric properties of these measures and which are the most established? 24 
Discussion 26 
References 30 
Appendix A: Guidance for publication in Journal of the International Neuropsychological Society
 37 
Psychological, Interpersonal and Social Functioning in Multiple Sclerosis: The Role of 







Affective Theory of Mind Measures 47 
Neuropsychological Measures 47 
Self-Report Measures 49 
Proxy Measures 50 
Procedure 50 
Data Analysis 51 
Results 53 
Descriptive Statistics 53 
Table 1: Comparisons between MS psychometric test and self-report questionnaire scores with 
normative data sample 53 
Relationships between demographic variables and TOM abilities 54 
Table 2: Correlations between TOM ability and demographic variables 54 
Relationships between TOM and cognitive abilities, and psychosocial outcomes 54 
Regression Analyses 55 




Appendix A: Guidance for publication in Journal of the International Neuropsychological Society 67 
Appendix B: Sample items from the Reading the Mind in the Eyes Test (Baron-Cohen et al., 2001) 70 
Appendix C: Sample Items from the Faux Pas Test (Baron-Cohen et al., 1999; Stone & Baron-Cohen, 
1998) 71 
Appendix D: Study Protocol 72 
Background 75 
Multiple Sclerosis 75 
Cognitive Functioning in MS 75 
Social Cognition/ Theory of Mind in MS 76 
TOM Based Interventions 77 
Rationale for Study 77 
Study Objectives 77 
Primary Objective 77 
Secondary Objectives 77 
Study Design 78 
Procedure 78 
Study Participants 79 
Number of Participants 79 
Inclusion Criteria 79 
Exclusion Criteria 80 
Participant Selection and Enrolment 81 
NHS Fife 81 
NHS Lothian 81 
Consenting Participants 81 
Withdrawal of Study Participants 82 
Partners and/or Significant Other 82 
Identifying Participants 82 
Inclusion Criteria 82 
Exclusion Criteria 82 
 5 
Withdrawal of Study Participants 83 
Study Assessment 83 
Data Collection 85 
Source Data Documentation 85 
Statistical and Data Analysis 85 
Sample Size Calculation 85 
Proposed Analyses 86 
1. Demographics 86 
2. Primary research question 86 
3. Secondary research questions 86 
Risks 86 
Oversight Arrangements 87 
Inspection of Records 87 
Study Monitoring and Audit 87 
Good Clinical Practice 87 
Ethical Conduct 87 
Investigator Responsibilities 88 
Informed Consent 88 
Study Site Staff 88 
Data Recording 88 
Investigator Documentation 88 
Confidentiality 88 
Data Protection 89 
Study Conduct Responsibility 89 
Protocol Amendments 89 
Management of Protocol Non-Compliance 89 
Serious Breach Requirements 90 
Study Record Retention 90 
End of Study 90 
Insurance and Indemnity 91 
Reporting, Publications and Notifications of Results 91 
Authorship Policy 91 
References 91 
Appendix E: Letter of Favourable Ethical Opinion from South East Scotland Research Ethics Committee 93 
Appendix F: NHS Fife Research and Development Approval 97 
Appendix G: NHS Lothian Research and Development Approval 99 
Appendix H: Participant Information Sheet 100 
Appendix I: Consent Form 104 
Full Thesis References 105 
 6 
 
Thesis Abstract  
Theory of Mind (TOM) is an important ability in guiding social behaviour, with impairments in 
TOM being associated with psychosocial difficulties. Over recent years, individuals with 
multiple sclerosis (MS) have been consistently shown to have impaired TOM abilities, 
however, little is known about the psychosocial impact of these impairments in this 
population. This thesis has two sections. Initially, a systematic review was completed that 
assessed and compared the psychometric properties of the TOM measures which have been 
used with individuals with MS. This highlighted that seventeen different TOM measures have 
been used with individuals with MS. Through exploring the psychometric properties of these 
seventeen measures, it was revealed that no measure has been validated on an MS sample 
and more generally there was little information about the psychometric properties of these 
measures. Whilst recommendations are tentatively made on TOM measure selection for 
individuals with MS, the paper discusses the remaining challenges in measure selection, 
accuracy of measurement and the need for further research into these measures. Secondly, 
an empirical study explored the relationships between TOM abilities and psychosocial 
outcomes in individuals with MS. In total, 36 individuals participated, which involved 
completing neuropsychological tasks of TOM and executive functioning abilities, as well as 
self-report measures of their psychological, interpersonal and social abilities. Results 
indicated that TOM was not associated with psychological, interpersonal and several areas of 
social functioning, however, TOM performance was significantly related to social withdrawal, 
employment and quality of life. These findings are discussed and areas for future research 
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Background: Theory of Mind (TOM) abilities are important in guiding an individual’s social 
behaviour and supporting their interactions with others. Impairments in TOM have been 
linked to poorer psychosocial outcomes, including lower quality of life and depressive 
symptomology. Individuals with Multiple Sclerosis (MS) have been consistently shown to have 
impaired TOM. Accurate measurement is critical for identifying impairments and individuals’ 
needs, and for intervention planning.  
 
Objective: This review aimed to summarise the TOM measures that have been used to explore 
TOM abilities in individuals with MS and to assess and compare the psychometric properties 
of these measures.  
 
Method: Systematic literature searches were performed in Ovid using the PsycINFO, Embase, 
Ovid MEDLINE and Epub databases. To be included, studies had to report using at least one 
TOM measure with an MS sample. The psychometric quality of the measures was assessed 
using published quality assessment criteria.  
 
Results: In total, twenty-eight studies, which used a range of seventeen different measures of 
TOM, were included in this review. There was wide variation in the reported psychometric 
information for the various TOM measures, with large amounts of missing information 
limiting the ability to review and compare psychometric properties across the TOM measures. 
Only five of the seventeen measures scored more than half marks on the quality assessment 
measure. No TOM measure had been specifically validated on an MS sample and only a few 
validated on other neurological populations.  
 
Conclusions: The most psychometrically established measures of TOM are reported, and 
recommendations are tentatively made surrounding appropriate measure selection within an 
MS sample. There are significant gaps in the reported psychometric properties of TOM 
measures. Future work is necessary to address these gaps and to explore more fully their 




There is an ongoing challenge within the field of psychology to develop neuropsychological 
tests which are accessible to all, but are also able to identify subtle cognitive dysfunction 
(Baron-Cohen, Wheelwright, Hill, Raste, & Plumb, 2001). One particular neuropsychological 
domain where this is a challenge is Social Cognition (SC). SC is the umbrella term for a number 
of cognitive abilities which are used to guide our behaviour and support successful interaction 
with others (Lysaker, Dimaggio, & Brüne, 2014). One SC ability which has generated a lot of 
research interest in a variety of populations is Theory of Mind (TOM), which refers to an 
individual’s ability to attribute the mental states of oneself and others (e.g. their beliefs, goals, 
intentions and emotions; Banati et al., 2010). TOM itself is also a multifaceted construct, used 
to explain several cognitive skills which are acquired at different developmental stages, 
including understanding mental states and recognition of social faux pas. 
 
Research has shown that in neurotypical children, these TOM abilities start to develop 
between the ages of three and four years (Wimmer & Perner, 1983) and continue to develop 
in a hierarchical fashion. Children initially develop the ability to complete first-order false 
belief tasks (i.e. those which assess an individual’s knowledge that others may have a different 
mental representation than them and therefore can hold a false belief; Wimmer & Perner, 
1983). Then around the age of six and seven years they acquire the capacity to understand 
and make inferences about another individual’s mental state and complete second order 
false-belief tasks (i.e. those that assess an individual’s ability to understand what someone 
thinks about what another individual thinks; Stone, Baron-Cohen, & Knight, 1998; Wimmer & 
Perner, 1983). Finally, around the ages of nine to eleven years, children become able to 
recognise and understand social faux pas (Stone & Baron-Cohen, 1998).  
 
The development of these skills is not only of crucial importance as they drive social 
behaviour, allow individuals to connect with others, develop relationships and act in “socially 
appropriate ways” (Kennedy & Adolphs, 2012), but they also have wider implications on an 
individual’s physical and mental health. This has been highlighted through research in a range 
of populations who are known to have impaired TOM, including individuals with autism 
spectrum disorder (Baron-Cohen, Leslie, & Frith, 1985; Moran et al., 2011) and schizophrenia 
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(Harrington, Langdon, Siegert, & McClure, 2005; Lysaker et al., 2014). Research has evidenced 
relationships between impaired TOM abilities and: depressive symptomology (Wang et al., 
2018); lower quality of life (Canty, Neumann, Fleming, & Shum, 2017); and fewer and poorer 
quality social relations (Brüne, Abdel-Hamid, Lehmkämper, & Sonntag, 2007; Kennedy & 
Adolphs, 2012).  Therefore, the capacity to measure these abilities may help identify 
individuals who are in need of psychosocial support. 
 
In recent years there has been increased research interest into cognitive functioning, 
including social cognition abilities in individuals with Multiple Sclerosis (MS). This work has 
consistently highlighted impaired TOM abilities when compared against matched control 
samples (Cotter et al., 2016). Research into TOM abilities in MS is ongoing and gaps remain in 
our understanding in comparison to TOM abilities in other populations, such as individuals 
with autism spectrum disorder or schizophrenia. Given the significant wider implications of 
impaired TOM on other health and psychosocial outcomes it is important that accurate, 
comprehensive and ecologically valid TOM assessments are available for individuals with MS 
(McDonald et al., 2006). These assessments are relied upon for identifying TOM impairments 
and informing rehabilitation interventions.  
 
Currently, there are a large number of assessments available to assess TOM abilities at the 
various developmental levels. Within the MS research to date, a large variety of TOM 
measures have been used across studies (Cotter et al., 2016). This includes assessments such 
as the Sally-Ann doll task (Wimmer & Perner, 1983) which assesses false belief, the Reading 
the Mind in the Eyes Test (Baron-Cohen et al., 2001) which assesses mental inferencing and 
the Faux Pas Test (Stone, Baron-cohen, & Knight, 1998) assessing faux pas recognition and 
understanding. Whilst these measures have been tested, adapted, used and evaluated in 
some populations, it remains unclear which are more suitable for use with individuals with 
MS, and more generally there remains debate over their development, administration and 
interpretation (Canty et al., 2017). 
 
Many TOM tasks were developed for use with young children (e.g. the Sally-Ann doll task). 
Individuals with Autism Spectrum Disorder, who are known to have impaired TOM abilities, 
have been shown to pass these tasks (see Dziobek et al., 2006), which questions whether 
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these tasks would be able to identify mild cognitive dysfunction in adults of normal 
intellectual functioning (Baron-Cohen et al., 2001). Similarly, most TOM tasks primarily target 
one of the three developmental stages and therefore successful completion of one task does 
not necessarily generalise across all TOM abilities. This is of crucial consideration when 
comparing performance across studies, as results will likely be dependent upon the task 
administered. A further challenge in assessing TOM is the administration burden, given the 
ongoing debate surrounding the influence of other cognitive abilities (e.g. executive functions 
and verbal IQ) on task performance (Wade et al., 2018). This means that in clinical practice 
several tests have to be completed to ensure more accurate conclusions are drawn. Finally, 
there has been an ongoing drive in recent years to develop more advanced, ecologically valid 
measures of TOM, given the criticism of earlier tasks that performance is not generalisable to 
daily life and that researchers were in fact making broad conclusions from tests that 
measured a very narrow function (Canty et al., 2017). Despite efforts to make tests more 
ecologically valid there remains some debate regarding the extent to which this has been 
successful (Lancaster, Stone, & Genova, 2019). 
 
It is important to acknowledge that whilst there are critiques, many of these measures have 
been validated across a range of populations (Baron-Cohen et al., 2001; Happé, 1994;  Stone 
et al., 1998).  However, as these measures have not been validated on a MS sample, it remains 
unclear which measures are most suitable for use with individuals with MS.  Additionally, to 
date no reviews have been completed to compare and evaluate TOM assessment measures 
in any population sample, and rather a test’s psychometrics have been explored in isolation. 
Therefore, it remains unclear which measures are the most psychometrically established in 
the literature. As TOM in MS is an ongoing topic of research interest, the current review had 
two main aims, to: 
1. identify tasks/ tests/ instruments which have been used to assess TOM in 
individuals with a diagnosis of MS; and 
2. assess and compare the psychometric properties of these measures against 





The review protocol was registered on PROSPERO (registration number: CRD42020169274).  
 
 Search Strategy 
Once the general topic area of Theory of Mind (TOM) assessment in individuals with Multiple 
Sclerosis (MS) was identified, scoping searches were carried out to ascertain the volume and 
type of papers/evidence available for inclusion in this review. Following this, systematic 
literature searches were run in Ovid using the PsycINFO (1806 to January week 2 2020), 
Embase (Classic and 1947 to 2020 January 17), and Ovid MEDLINE(R) and Epub (Ahead of 
Print, In-Process & Other Non-Indexed Citations and Daily 1946 to January 17th, 2020) 
databases to identify all papers which assessed TOM abilities in individuals with MS. Searches 
were limited to studies published in English with human participants. The full search string 
entered and run in Ovid is outlined in Table 1. The search was completed on 19th January 
2020.  
 
Table 1: Advanced Search String Run in Ovid  
1 Theory of mind 
2 TOM  
3 Social cognit* 
4 Mentali* 
5 1 or 2 or 3 or 4 
6 Multiple Sclerosis 
7 MS 
8 6 or 7  
9 5 and 8 
10 Removed duplicates from 9 
 
 Inclusion and Exclusion Criteria 
Studies were included in this systematic review if they met the following criteria: (i) the study 
population was individuals with MS; (ii) the study utilised an instrument to explicitly and 
objectively measure TOM abilities; (iii) the study was published in English; and (iv) the study 
was an empirical paper. Exclusion criteria included: (i) articles studying a paediatric MS 
population; (ii) review or theoretical articles; and (iii) articles in unpublished grey literature. 
 
 13 
 Study Selection  
In total, the search of OVID retrieved 978 articles (see Figure 1 below for PRISMA flow chart 
of study selection process). After duplicates were removed on Ovid, citations and abstracts 
were exported into excel and were screened by the first author. Title, abstract and full text 
screening was done solely by the first author. Reference lists from identified articles were also 






































Figure 1: PRISMA flow chart of study selection process 
Records identified through 
database screening 
(n=978) 
Records excluded after: 
Title Screen (n= 460) 
Abstract screen (n=81) 
Full-text articles screened for 
eligibility 
(n= 90) 
Studies meeting eligibility 
criteria 
(n=27) 





63 records excluded: 
 
- Published in another 
language (n=1) 
- TOM not measured (n=7) 
- Not an empirical paper 
(n=52) 
- Duplicates (n= 1) 
- Grey literature (n=2) 
Records identified through 
screening reference lists 
(n=1) 





From each of the studies, descriptive information was gathered on sample size, MS diagnosis 
type, TOM measures used, date and country. In total, there were 17 different TOM 
measures/assessments identified across the 28 studies. Additionally, any reported 
psychometric properties of the TOM measure(s) were recorded.  
 
Following data extraction from the studies measuring TOM in MS, the first author searched 
the literature for the original, and any subsequent study which aimed to validate each of the 
identified TOM measures. Original validation papers were identified from reference lists, with 
further searches for further validation papers being identified through searches on the 
university database. Specifically, this involved searching within OVID for validation papers for 
each of the TOM measures. All psychometric data on the TOM measures was extracted and 
assessed against quality criteria. 
 
Quality Evaluation/ Assessment  
The psychometric properties for each measure, reported either in the 28 papers identified 
through the systematic search or from validation studies, were reviewed and assessed against 
quality criteria (Table 2), adapted from Terwee et al. (2007).  Their quality assessment criteria 
were used as they were developed specifically for assessing the measurement properties of 
health questionnaires. Whilst TOM measures are not health questionnaires, Terwee et al. 
(2007) work is the most closely related, has been used in similar systematic searches (e.g. see 
Fletcher, Flight, Gunn, Patterson, & Wilson, 2020; Hidding, Altenburg, Mokkink, Terwee, & 
Chinapaw, 2017; Strauss et al., 2016) and sets out clear definitions of explicit criteria for what 
constitutes good measurement properties. Two of the criteria assessed by Terwee et al. 
(2007) were not rated in the current review: “criterion validity” (the extent to which scores 
on a particular instrument relate to a gold standard) and “responsiveness” (the ability of a 
questionnaire to detect clinically important changes over time). This was due to there not 
being a clear gold standard TOM measure to compare against and because the TOM measures 
are not primarily designed to measure clinically meaningful change over time, respectively.  
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In comparison with Terwee et al. (2007) who uses  (+), (?), (-) and (0) ratings, here numerical 
values were used, similar to that Strauss et al. (2016), to make the results easier to interpret 
(see Table 2 for specific criteria). The maximum possible quality assessment score for any 
measure was 12, with higher scores being indicative of more established and validated 
measures. A second rater independently completed the quality analysis on a random 
subsample (29%) of the TOM measures and the inter-rater agreement was 89.58%.  Any 
disagreements in rating were discussed together and a decision made collaboratively.
Table 2: Quality Criteria for Assessment of Psychometric Properties (adapted from Terwee et al., 2007, and scoring informed by Strauss et al., 2016) 
MIC = minimal important change; SDC = smallest detectable change; LOA = limits of agreement; ICC = Intraclass correlation; SD = standard deviation.  
a  2 =positive rating; 1 = indeterminate rating;  0= negative rating OR no information available.  
b  Doubtful design or method=  lacking a clear description of the design or methods of the study, sample size smaller than 50 subjects (should be at  least 50 in every (subgroup) analysis), or any important methodological weakness in the 
design or execution of the study.  
16 
Property Definition Criteria a b   
Content Validity 
 
The extent to which the concepts of interest are 
comprehensively represented by the items in the 
questionnaire  
 
2 A clear description is provided of the measurement aim, the target population, the concepts that are 
being measured, and the item selection  
1 A clear description is lacking OR only target population involved  
0 No target population involved OR No information found on target involvement   
Internal 
Consistency 
The extent to which items in a (sub)scale are 
correlated, thus measuring the same concept  
 
2 Cronbach’s alpha calculated per dimension AND Cronbach’s alpha between 0.70 and 0.95 
1 Cronbach’s alpha not calculated for each dimension OR doubtful design or method 
0  Cronbach’s alpha <0.70 or .0.95, despite adequate design or methodology OR No information found 
on internal consistency 
Construct 
Validity  
The extent to which scores on a particular 
instrument relate to other measures in a manner 
that is consistent with theoretically derived 
hypotheses concerning the concepts that are 
being measured  
2 hypotheses are specified in advance AND at least 75% of the results are in correspondence with 
these hypotheses 
1 doubtful design or method (e.g. no hypotheses) 
0 Less than 75% of hypotheses confirmed, despite adequate design and method OR No information 
found on construct validity  
Reliability  
 
The extent to which respondents can be 
distinguished from each other, despite 
measurement error 
2 ICC or weighted Kappa ≥0.70 
1 doubtful design or method (e.g. no time interval mentioned) 
0 ICC or weighted Kappa <0.70, despite adequate design and method OR No information found on 
reliability  
Floor and Ceiling 
Effects 
The number of respondents who achieved the 
lowest of highest possible score 
2 ≤15% of the respondents achieved the highest or lowest possible scores 
1 Doubtful design or method 
0 >15% of the respondents achieved the highest or lower possible scores, despite adequate design 




The degree to which one can assign qualitative 
meaning to quantitative scores  
2Mean and SD scores presented of at least four relevant subgroups of patients and MIC defined 
1 Doubtful design or method OR less than four subgroups OR no MIC defined 





What measures have been used to measure Theory of Mind in individuals with 
Multiple Sclerosis? 
In total, 17 Theory of Mind (TOM) measures were identified from the 28 studies of TOM in 
individuals with Multiple Sclerosis (MS). These 28 studies were conducted across 13 countries, 
with sample sizes ranging from 15 to 64 (M=40.71, SD= 15.02). All demographic information 
from the TOM in MS studies is reported in Table 3. Additionally, a brief summary of each of 
the 17 TOM measures used with individuals with MS is reported below.  
 
The frequency of TOM measure use varied greatly. The adult eyes test was the most 
commonly used measure of TOM within the MS population, with 14 of the 28 papers using it. 
The faux pas, or an adapted version of the faux pas test was the second most common 
measure used in eight of the papers. In contrast, several measures were only used in one of 
the papers: Bordeaux social cognition assessment; conversation and insinuations task; 
emotional attribution task; Genova social cognition scale; mini social cognition and emotional 
assessment; TOM picture sequencing task and the virtual assessment of mentalising ability.  
 
Baron-Cohen Adult Eyes Test (Baron-Cohen et al., 2001) 
This test, also known as the Reading the Mind in the Eyes test (RMET), is made up of 36 
photographs showing a set of eyes, each portraying different complex mental states. No other 
facial features are shown. For each set of eyes, the participant is asked to select one of four 
emotions which best describes the mental state of the individual in the picture. A point is 
awarded for each correctly identified mental state, with higher scores being indicative of 
better performance.  
 
Baron-Cohen Adult Faces Test (Baron-Cohen, Wheelwright, & Jolliffe, 1997) 
This task consists of twenty photographs, all of the same actress from the shoulders upwards, 
who is displaying different complex mental states. The participant has to choose one of two 
words which are printed below each photograph that best represents the emotion or mental 
state portrayed by the face. Each correctly identified emotion/mental state is awarded a 
point, with larger scores denoting better performance.  
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Bordeaux Social Cognition Assessment Protocol (Etchepare et al., 2014) 
The Bordeaux Social Cognition Assessment Protocol is made up of seven recognised tests of 
Social Cognition. Whilst it assesses TOM using the Faux Pas, Attribution of Intentions and 
Baron-Cohen’s Eye Tests, and facial emotion recognition through the Adult Faces Test, it also 
measures other social cognition abilities such as emotional awareness, emotional fluency and 
alexithymia through other subtests. Information for the faces, eyes and faux pas’ tests are 
reported separately (see test description). The attribution of intentions test is made up of 30 
comic strips involving human figures. Each comic strip comprises of three pictures which 
represent a short story. Individuals then choose one of three further pictures which provides 
a logical end to the story. The protocol for the Bordeaux social cognition assessment is written 
in French and as far as the author is aware, has not been translated or used within other 
language populations. Due to the translation barrier, it is not possible to identify if or how the 
subtest scores are combined into an overall score of social cognition ability.  
 
Conversation and Insinuations (Ouellet et al., 2010) 
This is a video task comprising of four clips, each lasting around two minutes. The video is 
paused approximately every 20 seconds and the individual asked a question about a 
character’s response. Each response included one of the following language acts: irony, faux 
pas, lies or indirect messages (Ouellet et al., 2010). Individuals have to select the correct 
answer from four possible answers which appear on the screen.  
 
Emotion Attribution Task (Blair et al., 1995) 
The Emotional Attribution Task consists of between 9 and 35 short social stories, depending 
on the task version. Once each story has been read out, individuals are asked how they think 
the main character in the story would be feeling. For each correctly identified emotional state 
individuals are awarded a point, with higher scores illustrating better performance. 
 
False Belief Tasks (Baron-Cohen et al., 1985; Rowe, Bullock, Polkey, & Morris, 2001) 
Two of the papers (Henry et al, 2011, 2017) used false belief tasks, which they describe as 
being based upon the work of Baron-Cohen, Leslie, & Frith, (1985) and Rowe, Bullock, Polkey, 
& Morris, (2001). They stated using two first-order false belief tasks (assessing an individual’s 
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ability to recognise that someone can hold a mistaken belief that is different from their own 
true belief), two second-order false belief tasks (assessing an individual’s ability to understand 
what another person thinks another person thinks) and 2 faux pas stories (see below). 
Following each story being read to them, participants were asked 4 questions to assess their 
identification and understanding of the false belief or faux pas present. Points were awarded 
for correct answers, with detection, understanding and total scores being generated.  
 
Faux Pas (Baron-Cohen, O’Riordan, Stone, Jones, & Plaisted, 1999; Stone et al., 1998) 
The Faux Pas Recognition Test (Baron-Cohen et al., 1999; Stone et al., 1998) comprises of 
twenty short vignettes, ten of which detail a situation where a ‘faux pa’ is present, whilst the 
other ten are control vignettes.  The faux pas and control stories are presented in a random 
order. If an individual identifies a faux pa to be present within a vignette, they are asked 
further questions which explore their detection of the faux pa and understanding of the 
character’s intentions and beliefs. Individuals had to answer all questions correctly for each 
faux pa to gain the point for that faux pa, with a total of 10 points available. One point for 
each faux pa story, with higher scores being indicative of better understanding of the faux 
pas.  
 
Faux Pas- Adapted (Henry et al, 2011, 2017) 
All nine studies that reported using the Faux Pas’ test with individuals with MS used an 
alternative or adapted version of the standard test developed by Stone et al., (1998). The 
adaptations made to the faux pas test were unique to and varied by study. This ranged from 
some studies using as few as two faux pas stories (Henry et al, 2011, 2017) to others using up 
to five. A few of the studies used only faux pas stories, whilst others also included control 
stories. It was unclear for several of the studies how many stories they had used from the 
original measure versus how many they had created. Whilst most of the adapted measures 
require individuals to identify and explain the faux pas, others only require the individuals to 




Genova Social Cognition Scale (Martory et al., 2015) 
The Genova Social Cognition Scale was developed from existing, recognised measures for use 
in everyday clinical practice. It comprises of six tasks, five of which assess social cognition and 
one assesses executive functioning. These include social cognition stories which assess false 
belief and faux pa recognition; 10 items from the reading the mind in the eyes test; cartoons 
assessing non-verbal false belief recognition; a social inference task and “absurd stories” 
which comprises of stories without social aspect. Scores are generated for each test, with full 
points being given to complete answers and half marks given to incomplete or correct 
answers without explanation.  
 
Mini Social Cognition and Emotional Assessment (Bertoux et al., 2012, 2014) 
This is a shorter version of the Social Emotional Assessment Test. It comprises of an 
abbreviated version of the Faux Pas test and the Facial Emotion Recognition test. The faux 
pas component comprises of 10 vignettes, which requires the individual to identify a Faux Pa 
if it occurred (n=5). The facial emotion recognition test used 35 faces from the Ekman faces 
test, a test of emotion recognition. Individuals are asked to identify the emotion a face is 
displaying.  Each test is scored individually, as per test scoring instructions, before scores 
being added together to form a total score. 
 
Movie for the Assessment of Social Cognition (Dziobek et al., 2006) 
This test involves watching a 15-minute video about four individuals at a dinner party. The 
video is stopped on 46 occasions and the participants are asked questions about the 
characters’ thoughts, feelings and intentions. For each correct emotion identification 
participants are given one point, with all scores being added together to give a total score.  
 
Strange Stories (Happé, 1994) 
This task involves the participant reading 24 vignettes where someone says something they 
do not mean literally. There are 12 categories of stories (e.g. lie, white lie, misunderstanding, 
sarcasm, double bluff). Individuals’ comprehension is initially assessed by asking “is it true 
what X said?” then the justification is explored by asking “why did X say that?”. Additionally, 
there are 4 control questions which ask about physical events. A total of one point was 
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available per story and this was awarded based upon the subject’s justification of why X said 
what they did.  
 
Strange Stories- Adapted (Isernia et al., 2019; Raimo et al., 2017)  
Two studies (Isernia et al., 2019; Raimo et al., 2017) used alternative versions of the Strange 
Stories task developed by Happé (1994), however both made reference to this measure in 
their papers. Both papers used differing numbers of TOM and control stories. Scoring varied 
across studies with either one or two points being available per story. These were awarded 
based upon the completeness of the inference of mental state rather than a purely factual 
answer. 
 
The Awareness of Social Inferences Test (TASIT; McDonald et al., 2006; McDonald, 
Flanagan, Martin, & Saunders, 2004; McDonald, Flanagan, Rollins, & Kinch, 2003) 
The TASIT is a test made up of three parts, the first of which assesses emotional recognition 
followed by the latter two parts assessing TOM. Part two involves asking individuals to watch 
a series of vignettes of adults engaging in conversations and then asking them to determine 
whether their reactions were sincere or sarcastic. Part three asks individuals to decide 
whether the individual in the clip is deliberately concealing the truth through lying or through 
use of sarcasm. Questions are asked on what the speaker said, what they intended, how the 
protagonist would have felt and what was the unsaid message communicated. Scores were 
awarded for correct answers to each of these questions.  
 
The Theory of Mind Sequencing Task (Brüne, 2003) 
The Theory of Mind Sequencing Task comprises of only one story which is made up of four 
cartoon pictures. Initially, individuals are asked to sequence the pictures before being asked 
five questions: a first-order false belief question (“what does the monkey think is in the paper 
bag?”) followed by the subsequent reality question (“what is really in the paper bag?”), the a 
second-order false belief question (“what does the monkey think the maid intends?”) 
followed by being asked the reality question again (“what is really in the paper bag?”), then 
finally they are asked a tactical deception question (“what does the maid intend?”). There is 




TOM Video Task (Sullivan & Ruffman, 2004) 
The TOM Video Task involves watching 26 silent video clips showing characters’ interactions 
before choosing one of two words which best describes the thoughts or feelings of the 
character in the video, based on their body language. One point is given per correct answer. 
   
Virtual Assessment of Mentalising Ability (Canty et al., 2017) 
This virtual reality TOM assessment involves participants navigating round a shopping centre 
completing errands before answering a number of questions about the interactions they 
engage in. There are 10 social interactions, each followed by four multiple choice questions 
which explore first-order cognitive, second-order cognitive, first order affective and second-
order affective TOM. Discretion is given to the examiner whether they wish to use a three-
point scale to rate responses (0= impaired mentalising, 1= reduced mentalising, 2= accurate 
mentalising), or two-point scale to allow comparisons to be made with other TOM measures. 
Table 3: Sample Characteristics of Included Studies 
 
MASC= Movie for the Assessment of Social Cognition; NR= not reported; PPMS= Primary Progressive Multiple Sclerosis; PRMS= Primary Relapsing Multiple Sclerosis; RMET= Reading the Mind in the Eyes Test; RRMS= Relapsing 
Remitting Multiple Sclerosis; SPMS= Secondary Progressive Multiple Sclerosis; TASIT= The Awareness of Social Inference Test; TOM= Theory of Mind  
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Studies measuring TOM in individuals with MS 
 
Country TOM Tasks MS Subtype Number of 
Participants 
Banati et al. (2010) Hungary RMET; Faux Pas; Adult Faces RRMS (37); SPMS (3) 40 
Batista, Alves, et al. (2017) Portugal RMET; TOM video test RRMS (50); SPMS (10) 60 
Batista et al. (2017) Portugal RMET; TOM video test RRMS (50); SPMS (10) 60 
Batista et al. (2018) Portugal RMET; TOM video test RRMS (50); SPMS (10) 60 
Chalah et al. (2017) France RMET RRMS (3); PPMS (18); SPMS (17) 38 
Chanial et al.(2020) France Faux Pas RRMS (19); PPMS (1); SPMS (1) 21 
Ciampi et al. (2018) Chile Mini-Social Cognition and Emotional Assessment PPMS (23); SPMS (20) 43 
Czekóová et al. (2019) Czech Republic RMET RRMS (43) 43 
Dulau et al. (2017) France Bordeaux Social Cognition Assessment Protocol RRMS (30); PPMS (15); SPMS (15) 60 
Genova, Cagna, Chiaravalloti, Deluca, & Lengenfelder, (2015) USA TASIT RRMS (10); PPMS (2); SPMS (2); PRMS (1) 15 
Genova et al. (2019) USA RMET; Strange stories RRMS (17); PPMS (3); SPMS (3) 23 
Henry et al. (2015) France Faux Pas RRMS (64) 64 
Henry, Tourbah, Chaunu, Bakchine, & Montreuil, (2017) France False Belief Tasks; Faux Pas tasks  RRMS (31); PPMS (16); SPMS (15) 62 
Henry et al. (2011) France Faux Pas; False Beliefs Tasks RRMS (64) 64 
Henry et al. (2009) France RMET NR 27 
Isernia et al. (2019) Italy RMET; Strange Stories; Faux Pas; MASC RRMS (42) 42 
Kraemer et al. (2013) Germany MASC RRMS (25) 25 
Lancaster, Stone, & Genova, (2019) USA Virtual Assessment of Mentalising Ability PPMS (11); SPMS (4) 15 
Mike et al. (2013) Hungary RMET; Faux Pas; Adult Faces RRMS (44); SPMS (5) 49 
Neuhaus et al. (2018) Switzerland Geneva Social Cognition Scale RRMS (25); PPMS (8); SPMS (2) 35 
Ouellet et al. (2010) Canada Faux Pas; Strange Stories; Conversation and 
Insinuation Task 
RRMS (22); PPMS (5); SPMS (13); NR (1) 41 
Phillips et al. (2011) UK TOM video task RRMS (27); PPMS (2); SPMS (3) 32 
Pitteri et al. (2019) Italy RMET RRMS (31) 31 
Pöttgen, Dziobek, Reh, Heesen, & Gold, (2013) Germany MASC RRMS (31); PPMS (6); SPMS (8) 45 
Raimo et al. (2017) Italy RMET; Emotion Attribution Task; TOM Picture 
sequencing task; Adapted Strange Stories  
RRMS (36); PPMS (2); SPMS (2) 40 
Realmuto et al. (2019) Italy RMET RRMS (45) 45 
Roca et al. (2014) Argentina Faux Pas RRMS (5); PPMS (1); SPMS (29) 35 
Sofologi et al. (2019) Greece TASIT PPMS (25) 25 
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What are the psychometric properties of these measures and which are the most 
established? 
Using the adapted version of the Terwee et al. (2007) quality assessment criteria described in 
Table 2, the psychometric properties of each of these 17 measures were explored. The results 
are reported in Table 4, below. There was a lot of missing information in the psychometric 
information documented. Only five of the seventeen measures scored greater than, or equal 
to half points (6/12). These were: the adult eyes test, the MASC, strange stories, the TASIT 
and the Virtual Assessment of Mentalising Ability. In particular, information on reliability 
(internal consistency and reliability items) was often not reported.  The top scoring TOM 
measures assessed the range of TOM skills including false belief recognition and 
understanding, inferring of mental state and non-literal language interpretation.  
 
In addition to the information gathered by the quality assessment tool, this review aimed to 
explore additional psychometric information including e.g. the factor structures of the 
measures. However, only the RMET has had its factor structure explored.  The developers 
(Baron-Cohen et al., 2001) suggested that all items of the RMET are indications of a single 
factor model; however, later work has challenged this conclusion, and stated that the one 
factor structure does not demonstrate a goodness to fit and rather a five factor solution 
would be more appropriate (Olderbak et al., 2015). Therefore, there are questions regarding 
the internal consistency of this measure.  
 
It was not possible to complete the quality assessment for five of the identified measures. 
There were two main reasons for this: a lack of clarity around how the measures have been 
adapted and psychometrics reported in another language. Firstly, whilst the False Belief, 
Emotion Attribution and the adapted versions of both the Strange Stories and Faux Pas Tasks 
were based on earlier studies, the exact stories/items were not available, and were made up 
of additional or fewer items than the standardised measure. Therefore, it was not possible to 
gauge psychometric information from earlier work. Secondly, for the Bordeaux Social 
Cognition Assessment Protocol (PECS-B) and Conversations and Insinuations Task, 
psychometric properties have been explored but as they were reported in French (see 
Etchepare et al., 2014) they could not be understood or interpreted. 
Table 4: Quality Assessment of Measures 
N/K= not known, TASIT= The Awareness of Social Inference Test  25 






Reliability  Floor and 
Ceiling Effects 
Interpretability  Total 
Baron-Cohen Adult Eyes 
Test  
Baron-Cohen et al. (2001) Adults with ASD, and two 
control group 
2 0 2 0 2 1 7 
Olderbak et al. (2015) Amazon Mechanical Turk 2 0 0 0 1 0 3 
Baron-Cohen Adult Faces 
Task 
Baron-Cohen, Wheelwright, 
& Jolliffe, (1997) 
Adults and Adults with ASD 2 0 0 0 
 
0 1 3 
The Bordeaux Social 
Cognition Assessment 
Protocol (PECS-B) 
Etchepare et al. (2014) “Healthy” French 
Population 
- - - - - - N/K 
Emotion Attribution Task Blair et al. (1995) - - - - - - - - 
Conversations and 
Insinuations 
Ouellet et al. (2010) - - - - - - - N/K 
False Belief Task Baron-Cohen, Leslie, & Frith, 
(1985); Rowe, Bullock, 
Polkey, & Morris, (2001) 
- - - - - -  - - 
Faux Pas 
 
Stone, Baron-cohen, & 
Knight, (1998) 
patients with brain 
damage/ lesions 
1 0 1 0 0 1 3 
Faux Pas (Adapted) - - - - - - - - - 
Genova Social Cognition 
Scale  
Martory et al. (2015) Brain injured individuals 
and control group 
2 0 1 0 1 1 5 
Mini Social Cognition and 
Emotional Assessment  
Bertoux et al. (2012) Depression or Fronto-
temporal dementia  
1 0 1 1 0 0 3 
Bertoux et al. (2014) Frontotemporal dementia  1 0 0 0 0 0 1 
Movie for the Assessment 
of Social Cognition  
Dziobek et al. (2006) Individual’s with Asperger’s 
and controls  
2 2 0 2 2 1 9 
Fossati, Borroni, Dziobek, 
Fonagy, & Somma, (2018) 
adolescents, adults and 
individuals with personality 
disorder 
2 2 1 0 0 1 6 
Strange stories  Happé, (1994) Autism Spectrum Disorder 
and 3 control groups 
2 0 2 0 2 1 7 
Strange stories (adapted) - - - - - - - - N/K 
TASIT McDonald, Flanagan, Rollins, 
& Kinch, (2003) 
Neurologically normal 
population  
2 0 1 0 0 1 4 
McDonald, Flanagan, Martin, 
& Saunders, ( 2004) 
Adults with brain injury 2 1 1 0 0 1 5 
McDonald et al. (2006) Adults with brain injury 2 1 1 0 2 0 6 
The Theory of Mind 
Picture Sequencing Task 
Brüne, (2003) Individuals with 
schizophrenia 
1 0 1 0 0 1 3 
TOM Video Task  Sullivan & Ruffman, (2004) Older adults and younger 
adults 
2 0 0 0 0 1 3 
Virtual Assessment of 
Mentalising Ability 
Canty, Neumann, Fleming, & 
Shum, (2017) 




This review aimed to identify the specific measures used to assess Theory of Mind (TOM) in 
individuals with Multiple Sclerosis (MS), and to explore the psychometric properties of these 
measures to better understand which are the most psychometrically established within the 
current literature. Seventeen TOM measures had been used with an MS sample and these 
assessed TOM abilities across the various levels of the construct. Items exploring an 
individual’s ability to identify and understand another individual’s intentions were present 
across 14 of the measures, faux pas understanding was explored in 8 measures and false 
belief in 4 of them. Whilst it is important to remember the different TOM constructs 
measured by the various measures, the review found the Movie for the Assessment of Social 
Cognition (MASC; Dziobek et al., 2006; Fossati et al., 2018) was the most established measure 
of TOM in terms of the reported psychometrics, closely followed by the Adult Eyes (Baron-
Cohen et al., 2001), strange stories (Happé, 1994) and the Virtual Assessment of Mentalising 
Ability Tasks (VAMAT; Canty et al., 2017). This does not mean that the other assessment 
measures are not suitable for purpose or are invalid, but rather that their psychometric 
properties are less evidenced or reported within the literature.  
 
There are several potential reasons for why some TOM measures appeared to be more 
psychometrically established than others. It could be that they are not as reliable or valid in 
measuring the construct they were designed to. In these cases, the measures would have 
been given a lower rating on the assessment measure as their statistical output was in a less 
desirable range. However, this was not representative of the majority of lower quality ratings 
given in this review. Rather, lower scores were more commonly given as no psychometric 
information was reported. There was a large amount of missing psychometric information for 
these measures, particularly reliability ratings, floor and ceiling effects, and where measures 
used were adapted from other established measures (e.g. the adapted faux pas and strange 
stories tasks). Whilst the authors likely made such adaptations to make the measure more 
accessible to their target population, there was no psychometric information available to 
show whether or not this process was successful. This missing information makes it 
challenging to draw conclusions about which measures assess particular constructs most 
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effectively. It would be useful for these gaps, as well as the factor structures, of TOM 
measures to be explored and for more informed conclusions to be drawn. 
 
Although the quantitative information generated from this review is informative in identifying 
the most psychometrically established TOM assessment measures, qualitatively there are 
many considerations to be made when interpreting the results and informing of measure 
selection for individuals with MS. Firstly, no measures have been specifically validated on an 
MS population, and rather the measures were validated on a range of populations from 
neurotypical adults, to individuals with Autism Spectrum Disorder (ASD) to individuals with 
other neurological conditions. This specific review aimed to understand TOM measurement 
in MS, a neurological condition (Feinstein, 2007); however, none of the more 
psychometrically sound measures (reported above) were validated on individuals with a 
neurological diagnosis of any kind. There is a large degree of variability in the cognitive 
profiles of different neurological conditions (see Husain & Schott, 2016), as well as between 
neurological and non-neurological (e.g. ASD and controls) conditions. Research has shown the 
TOM impairments in individuals with MS can be subtle and are not as severe as those 
identified in individuals with schizophrenia or other neurological disorders (Cotter et al., 2016, 
2018). Therefore, it is not clear based upon the current evidence whether these measures 
would be able to identify any subtle impairments in individuals with MS, if present. This ability 
of the assessment measures is of vital importance in ensuring accurate measurements as 
these assessments inform rehabilitation interventions (Canty et al., 2017). 
 
Secondly, many of the most commonly used measures were developed around twenty years 
ago. In these cases, it seems more likely that measures have become more established in the 
field due to their frequency of use, rather than their psychometric qualities (Olderbak et al., 
2015). This may explain why the Adult Eyes Test has been the most commonly used measure 
of TOM. It is not to say that these measures are not reliable; however, with little attempts to 
validate measures since, and on other population samples, it is not clear how sensitive they 
are to current population demographics and psychosocial behaviours. It would be interesting 
to assess how much overlap there is between these older and the more recent, 
psychometrically established measures in their assessment of the same TOM construct. 
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Future studies may wish to consider using more than one measure of TOM to better 
understand the concurrent validity across these. 
 
Additionally, this review has highlighted the wide geographical spread of completed studies. 
This means that many of the measures have either been written/developed in another 
language or have required translation to be used. In addition to the potential challenges of 
direct translation of text into another language, there is also cultural variations in “socially 
appropriate” behaviours and ways of interaction with others (House et al., 2013). This could 
have potential implications on normative data and scoring as there will likely be some 
subjective differences in ratings across cultures. Where possible, researchers should consider 
the population in which measures have been developed as this may impact upon their ability 
to identify and record TOM abilities across cultures.  
 
One of the key limitations of this review is that it did not explore ecological validity as part of 
the quality assessment measure. This was partly due to the quality assessment being 
informed by previous work (Terwee et al., 2007) and only minor adaptations being made. 
Whilst ecological validity may not be of as great importance in other areas of clinical health 
measurement (e.g. physical health studies), in TOM this is of crucial importance as TOM 
abilities have a direct impact on many psychosocial outcomes (Brüne et al., 2007; Kennedy & 
Adolphs, 2012; Wang et al., 2018). Therefore, it should be a key consideration in the selection 
of assessment measures used in both research and clinical practice (Sbordone, 2001). In 
recent years an increased number of measures have been developed, with the primary aim 
of them being more ecologically valid. This has included using videos of everyday interactions 
and Virtual Reality technology in the development of measures. The results of this review 
suggest that some of the more recently developed measures, which aimed to be more 
ecologically valid (e.g. the MASC and the VAMAT), are amongst the most psychometrically 
sound, however, to date they have only been validated on a small selection of clinical 
populations. It is recommended that further research is carried out on these measures to 
assess their suitability for use with a neurological population, which will promote accurate 




In summary, this paper aimed to review the existing psychometric literature on measures of 
TOM in individuals with MS. Whilst it is not possible to draw firm conclusions on which TOM 
measures are most suitable for use with individuals with MS, this review tentatively would 
recommend the use of the MASC in clinical practice due to its higher overall rating, good 
content validity and adequate interpretability. Additionally, using this alongside the Adult 
Eye’s test would be beneficial in allowing comparisons to be made with existing studies of 
TOM in MS as it has been the most used measure to date.  The VAMAT may be a good choice 
of measure for research purposes, however, requires further assessment of its interpretability 
before firmer conclusions can be made surrounding it’s suitability for use in clinical practice. 
In addition to identifying the most established measures in the evidence base, this paper has 
also highlighted the significant number of existing gaps and the urgent need for further work 
to better understand the utility and accuracy of TOM measures. This is particularly true for 
their sensitivity to identifying subtle impairments within neurological populations. Until such 
work is completed research into TOM in MS can and should continue, however, researchers 
may wish to give additional consideration to the selection of assessment measures. This may 
include using multiple measures and also exploring and reporting the internal consistency of 
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Background: Research has consistently shown Theory of Mind (TOM) impairments in 
individuals with Multiple Sclerosis (MS), when compared to a matched control group. TOM 
impairments have been linked to poorer psychosocial outcomes in other clinical populations, 
however, the association between TOM and psychosocial outcomes in individuals with MS 
remains unknown. 
 
Objective: This exploratory study aimed to explore the associations between TOM abilities 
and interpersonal, psychological, and social functioning in individuals with MS. 
 
Method: Thirty-six individuals with a diagnosis of MS completed the Faux Pas and Reading the 
Mind in the Eyes (RMET) tests of TOM.  Neuropsychological assessments of executive abilities 
and self-report measures of psychological, interpersonal and social functioning were also 
completed.  
 
Results: Participants performed similar to normative control samples on all TOM and 
executive functioning measures. Additionally, they did not report impaired social functioning, 
relationship quality or depressive symptomology. Relationships were identified between 
TOM abilities and social withdrawal, employment and quality of life. 
 
Conclusions: In summary, relationships were identified between TOM and some areas of 
social functioning, but not psychological or interpersonal functioning. Compared to previous 
research, the current sample showed fewer cognitive impairments, therefore, further work 
exploring these relationships in a more cognitively diverse sample is recommended. 






Multiple Sclerosis (MS) is a chronic, inflammatory disease of the central nervous system, 
characterised by demyelination and widespread lesions or plaques on the brain and spinal 
cord (Feinstein, 2007). The location of these lesions is unpredictable and varies across 
individuals (Giovannoni et al., 2016). Individuals with MS can, therefore, experience a broad 
range of symptoms depending upon the location and extent of their myelin damage (Costello 
& Newsome, 2016). Additionally, symptoms vary by MS diagnostic subtype (Feinstein, 2007), 
with each having a different disease course. The most prevalent subtype is relapsing-remitting 
MS (RRMS), which approximately 85% of individuals are initially diagnosed with. Individuals 
with RRMS experience acute relapses characterised by neurological deterioration, followed 
by a period of (full or partial) recovery (Feinstein, 2007). Between relapses their presentation 
remains stable. Some individuals with RRMS will later develop secondary progressive MS 
(SPMS), which is characterised by progressive deterioration, with or without the relapses. 
Alternatively, around 15% of individuals are initially diagnosed with primary progressive MS 
(PPMS), which is characterised by gradual, continuous deterioration in neurological 
functioning (Feinstein, 2007) with no acute relapses.  
 
Individuals with MS can present with motor, visual, neuropsychological and cognitive 
difficulties (National MS Society, 2014; Niino, 2016). Whilst previously research into 
symptomology in MS has primarily focused on physical symptoms, more recently research 
assessing cognitive symptoms have been gathering more interest (Niino, 2016). Cognitive 
difficulties are extremely common in individuals with MS, with between 40 and 60% of 
individuals displaying some form of cognitive impairment (Bobholz & Rao, 2003; Chiaravalloti 
& DeLuca, 2008; Cotter et al., 2016); although, impairments are more frequently reported in 
individuals with SPMS (DeLuca, Chelune, Tulsky, Lengenfelder, & Chiaravalloti, 2004). 
Impairments have been identified across a range of cognitive abilities: between 40 and 60% 
of individuals with MS display deficits in memory and new learning (Winkelmann, Engel, Apel, 
& Zettl, 2007); 12 to 25% display difficulties with sustained attention and slower information 
processing speed (Chiaravalloti & DeLuca, 2008; DeLuca et al., 2004); and up to 19% of 
individuals have difficulties with executive functioning (Chiaravalloti & DeLuca, 2008; Rao, 




Whilst several neuropsychological characteristics of MS have been extensively researched 
and evidenced, until recently social cognition (SC) had been less widely explored and 
understood (Cotter et al., 2016). SC refers to the ‘mental operations that underlie social 
interactions’ (Cotter et al., 2018, p.92) and is an umbrella term for a number of cognitive 
abilities including emotion recognition, theory of mind (TOM), and empathy (Lysaker et al. 
2014). SC abilities are important in helping individuals to understand and make inferences 
about their own and others’ thoughts and feelings. This information informs and guides their 
behaviour, appropriate to their social context. Individuals with MS have been consistently 
shown to have impaired SC abilities when compared to a matched control sample (see 
Gleichgerrcht et al., 2015; Henry et al., 2011; Lenne et al., 2014; Ouellet et al., 2010; Phillips 
et al., 2011). This includes impairments in TOM, which refers to an individual’s ability to 
attribute the mental states of oneself and others (e.g. their beliefs, goals, intentions and 
emotions; Banati et al., 2010), which is crucial in understanding and predicting others’ 
behaviour. A recent meta-analysis (Cotter et al., 2016) exploring TOM in individuals with MS 
showed these abilities to be consistently impaired, with the magnitude of these impairments 
being equivalent to or greater than impairments in other cognitive domains. Although TOM 
impairments have been evidenced in a range of MS samples and using various measures of 
TOM, there has been limited research into the impact of these impairments on an individual’s 
daily life and functional abilities (Henry et al., 2011).  
 
The neurocognitive, neuropsychological and social implications of TOM impairments for 
individuals with MS are not yet known. Several studies have explored the relationship 
between TOM and neurocognitive abilities. Associations have been identified between TOM 
and several neurocognitive abilities, specifically executive functioning (Henry et al., 2009), 
working memory (Genova, Cagna, Chiaravalloti, Deluca, & Lengenfelder, 2016) and 
processing speed (Henry et al., 2009; Pöttgen, Dziobek, Reh, Heesen, & Gold, 2013). Executive 
functions include the ability to focus attention, inhibit responses/behaviours and problem 
solve. All of these abilities likely contribute to TOM abilities as individuals are required to 
select the social stimulus to focus on, think and problem solve what the other individuals is 
thinking/feeling and inhibit any inappropriate or automatic behaviours. Ouellet et al. (2010) 
found TOM impairments to be greater in individuals with more severe neurocognitive 
impairment, however, other research has shown TOM impairments to exist in the absence of 
other neurocognitive or neuropsychological difficulties (Pöttgen et al., 2013). There is 
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variability in the strengths of associations reported between TOM and neurocognitive abilities 
across studies. This variability may be accounted for by small sample sizes, which increases 
the likelihood of type 2 errors (e.g. Henry et al., 2009; n=17), and the wide range of TOM 
measures used across studies. This makes it difficult to interpret research findings and 
compare results across studies. 
 
The associations between TOM impairments and psychological outcomes for individuals with 
MS also remains unclear, despite depression symptomology being higher in individuals with 
MS when compared to a control sample (Cotter et al., 2018). Several smaller studies have 
completed exploratory analysis into the link between TOM and depressive symptomology, 
however, no relationship was found. To the researcher’s knowledge, there has been no 
similar research exploring whether there are any relationships between TOM and 
interpersonal or social functioning in individuals with MS. It would be expected that 
impairments in TOM would have implications for interpersonal and social functioning due to 
the role of TOM abilities in facilitating the development of quality interpersonal relationships 
and subsequent successful social integration (i.e. in helping us tailor our speech to our 
interlocutor, identify mutual interests and guiding our behaviour; (Bora, Özakbaş, Velakoulis, 
& Walterfang, 2016)). Additionally, quality interpersonal relationships and social 
connectedness are thought to be protective against mental health difficulties (Teo, Choi & 
Valenstein, 2013). Associations have also been consistently highlighted between social 
interactions and quality of life, well-being and mental health (Schuster, Kessler, & Aseltine, 
1990). Therefore it is unsurprising that impaired SC abilities have also been linked to the 
development and maintenance of mental health concerns (Penton-Voak et al., 2017). This has 
not been explored within an MS sample, but similar associations would be expected.  
 
Research has consistently evidenced social difficulties (e.g. isolation, reduced independence) 
and cognitive impairments (e.g. slower processing speed, impaired TOM) in individuals with 
MS (Feinstein, 2007), however, the associations between them remain unclear. This 
exploratory study aims to explore and better understand the associations between these 
difficulties. This research is important in enhancing mental well-being in individuals with MS, 





Presently, these gaps in the research literature mean it is not possible to ascertain which areas 
of an individual’s functioning rehabilitation interventions should focus on. SC rehabilitation 
interventions are not evidenced or routinely offered to individuals with MS, although, 
preliminary research into SC interventions with individuals with schizophrenia has led to 
improvements in TOM abilities and had a positive impact upon social functioning (see Kurtz, 
et al., 2016). However, prior to future work exploring SC interventions for individuals with 
MS, a more comprehensive understanding of the implications of SC impairments in this 
population is sought. The current study aims to address this by exploring the associations 
between TOM abilities and social, emotional, neurocognitive and interpersonal functioning 
in individuals with MS. As this study is exploratory, it is not possible for prior hypotheses to 
be established and rather any significant findings will generate new hypotheses for future 






 Participants  
A power calculation, using GPower, revealed that 103 participants were required to detect a 
medium effect (beta= .8, alpha= .05) from a regression model with 7 predictor variables. The 
study recruited 39 individuals with Multiple Sclerosis (MS). Three individuals subsequently 
withdrew from the study. All three individuals completed the testing session but did not 
return their self-report questionnaires: one due to health concerns; one continually forgot to 
return the questionnaires and these were not received by the end date of the study; and 
finally the researcher was unable to make contact with the third individual post testing.  
Therefore, the final sample included 36 individuals with MS. All individuals had previously 
received a formal diagnosis of MS from a neurologist. Individuals were recruited through 
either the Physical Rehabilitation Service (NHS Fife) or the Anne Rowling Clinic (NHS Lothian), 
and identified by an MS nurse or research assistant from pre-existing service databases. 
Inclusion criteria were: (1) a diagnosis of MS and (2) aged between 18 and 65 years. Exclusion 
criteria were: (1) English as a second language, (2) no capacity to give informed consent, (3) 
history of substance abuse, (4) any diagnosis that would affects social or cognitive functioning 
(e.g. Autism Spectrum Disorder, Brain Injury, Dementia, Learning Disability, Psychosis) and (5) 
significant visual perceptual or verbal comprehension impairment.  
Measures 
The assessment measures used in this study were selected based upon their suitability and 
previous usage within an MS sample. For example, no assessment measures completed in 
person required the individuals to write, because motor impairments are often present in 
individuals with MS. Additionally, where available, the psychometric properties of the 
measures were identified, considered and informed the measure selection, with the more 
psychometrically established measures being chosen for inclusion. At present most of the 
measures considered/selected, with the exception of Quality of Life (QoL; Vickrey, 1995) and 
depression (Sacco et al., 2016) reported below, had not been validated with an MS sample. 
The general lack of validation evidence within MS samples meant measure selection was 
informed by the psychometric evaluations in other samples and the prior use of measures 




 Affective Theory of Mind Measures  
Two measures of affective TOM were used, the Reading the Mind in the Eyes Test (RMET; 
Baron-Cohen, Wheelwright, Hill, Raste, & Plumb, 2001) and Faux Pas Recognition Test (Baron-
Cohen, O’Riordan, Stone, Jones, & Plaisted, 1999; Stone, Baron-Cohen, & Knight, 1998). The 
RMET involves 36 administration items, each of which consists of an image of a pair of eyes, 
surrounded by four words detailing an emotion or mental state (see Appendix B for sample 
items). The participants were given a booklet containing all administration items and asked 
to select which emotion printed around the eyes best described the mental state or feeling 
expressed through the eyes.  The Faux Pas Recognition Test (Stone et al., 1998) comprises of 
twenty short vignettes, ten of which detail a situation where a ‘faux pas’ is present, whilst the 
other ten are control vignettes (see Appendix C for sample items). The faux pas and control 
stories are presented in a random order. Printed copies of the stories were provided to the 
participants and they were asked if a faux pa was present. If the participant identified a faux 
pa to be present within a vignette, they were asked 5 further questions which explored the 
participant’s detection of the faux pa and their understanding of the character in the story’s 
intentions and beliefs. One point was available for each of the faux pas stories, and individuals 
had to answer all 6 questions correctly to get the point. This scoring method was described in 
the test development paper (Baron-Cohen et al., 1999) and has been used in more recent 
studies which have used the original faux pas test (see Lecce, Ceccato, & Cavallini, 2019; 
Tenenbaum & Leonard, 2020).   
Whilst both the RMET and the Faux Pas Recognition Test have not been validated specifically 
on a MS sample, neither have other TOM measures (Gibson, Calia, Newman, & Harper, 2020). 
This has resulted in a wide range of TOM measures being used with individuals with MS (see 
Cotter et al., 2018; Gibson et al., 2020). Both the RMET and the Faux Pas Recognition Test 
have been used to assess social cognition in previous research with individual’s with MS (e.g. 
Banati et al., 2010; Ouellet et al., 2010). 
Neuropsychological Measures 
The Test of Pre-Morbid Functioning (TOPF; Wechsler, 2011) is a reading test which aims to 
estimate an individual’s pre-morbid cognitive function. Specifically, participants were given a 
card with 70 words printed on it, each of which have atypical grapheme to phoneme 
translations, and asked to read each aloud. The raw score was translated into an IQ estimate 
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using normative data tables. It has been shown to have high reliability (r ranging from .96-
.99) and concurrent validity with the WAIS-IV full-scale IQ (r=.70; Holdnack & Drozdick, 2009) 
The Verbal and Category Fluency (Delis, Kaplan, & Kramer, 2001) test from the Delis Kapan 
Executive Function Systems (D-KEFS) is a measure of executive functioning and specifically 
assesses an individual’s mental flexibility. Participants were given either a letter of the 
alphabet or semantic category (e.g. animals) and asked to generate as many words as possible 
within a minute, starting with that letter or fitting into the semantic category. There is one 
further subtest which asked individuals to switch between giving answers across two 
semantic categories (e.g. a piece of fruit, then piece of furniture then another piece of fruit 
and so on). All correct responses are summed together to generate total scores, which are 
transformed into standard scores (M=10, SD=3). Internal consistencies of the verbal fluency 
scale were good to strong (.77- .90) , whilst the category and switching fluency subscales 
ranged from poor to good (.61- .76 and .43- .68, respectively; Delis et al., 2001). Test-retest 
reliability for the verbal fluency (.67- .88) and category fluency (.70- .82) subscales was good, 
however, was poor for the switching subscale (.49- .65; Delis et al., 2001). 
The Hayling Sentence Completion Test (Burgess & Shallice, 1997) is a test of two parts. The 
initial part assesses initiation and response speed. Participants were asked to complete a 
sentence as quickly as possible. The second part assesses inhibition and response 
suppression, with participants being asked to complete sentences using a completely 
unrelated word. The test has been shown to have good test re-test reliability (.76; Burgess & 
Shallice, 1997) and adequate convergent validity with other measures of executive 
functioning (see Wood & Liossi, 2007). 
The Brixton Spatial Anticipation Test (Burgess & Shallice, 1996) is a measure of rule detection 
and set shifting. Participants were presented with a box consisting of ten circles, one of which 
is blue. The blue circle moves according to certain patterns and the participant had to follow 
the pattern and predict where the blue circle will move to on the next page. Similar to the 
Hayling Sentence Completion test, test re-test reliability has been shown to be good (.71) and 
the Brixton has also demonstrated adequate convergent validity with other executive 
measures (see Wood & Liossi, 2007). 
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Self-Report Measures  
The Beck’s Depression Inventory II (BDI-II; Beck, Steer, & Brown, 1996) is a measure of 
depression symptomology. It is a 21 item self-report questionnaire, which focuses primarily 
on the psychological, rather than physical symptoms of depression. Therefore, the 
participants’ scores are less likely to be influenced by the physical symptoms of MS than other 
measures of depression symptomology. The items are rated on a 4-point scale from 0 to 3. A 
total score is generated by summing all item scores, with higher scores being indicative of 
higher levels of emotional distress. The BDI-II has been found to have good internal 
consistency (Cronbach’s alpha= .89), good convergent and divergent validity with individuals 
with MS (Sacco et al., 2016). 
The Multiple Sclerosis Quality of Life- 54 (Vickrey, 1995) is a quality of life measure specifically 
developed for use with individuals with MS. It consists of 54 questions making 12 subscales, 
which combine to form two composite scores for both physical and mental health.  For each 
question, participants are asked to rate their responses using Likert scales of varying ranges. 
Higher scores are indicative of better perceived quality of life. This measure has been less 
widely used in research but has been shown to have good internal consistency, with 
Cronbach's alphas ranging from .75 to .96 (Vickrey, Hays, Harooni, Myers, & Ellison, 1995) and 
evidenced validity.  
The Revised Dyadic Adjustment Scale (RDAS; Busby, Christensen, Crane, & Larson, 1995) is a 
14-item measure of relationship quality, subdivided into three subscales: dyadic satisfaction, 
dyadic cohesion and dyadic consensus. Individual item scores are summed to make subscale 
scores, with higher scores being suggestive of better relationship quality. It is a shorter version 
of the original Dyadic Assessment Scale (Spanier, 1976).  Internal consistency has been shown 
to be good (Cronbach’s alpha ranging from .80 to .90), as well as construct validity, with the 
RDAS correlating with other measures of relationship quality (Busby et al., 1995). 
The Social Functioning Scale (SFS): Individual Version (Birchwood, Smith, & Cochrane, 1990) 
is a measure of social functioning. The SFS is designed to assess more fundamental elements 
of social functioning, as seen in chronic disorders. It comprised of 79 items which make up 
seven subscales: social engagement; interactional behaviour; prosocial activities; recreational 
activities; independence-competence; independence- performance and employment. Total 
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raw scores are translated into standardised scores using the normative table, with higher 
scores being indicative of higher levels of social functioning. It was developed for use with 
individuals with schizophrenia and has been shown to have good internal consistency 
(Cronbach’s alpha ranging from .69 to.85; Birchwood, et al., 1990) and construct validity, with 
scores on the SFS correlating with negative symptoms which contribute to deficits in social 
functioning (r=-.44). 
The DEX Questionnaire (Wilson, Alderman, Burgess, Emslie, & Evans, 1996) is a 20 item 
questionnaire designed to assess for behaviours associated with dysexecutive syndromes 
including emotional or personality changes, motivational changes, behavioural changes and 
cognitive changes. There are two versions of this questionnaire, a self-rated and independent 
rated, made up of 20 items which are rated on a 5-point scale. Total scores are calculated by 
summing scores on individual items, with higher scores being indicative of greater difficulty. 
The DEX has been evaluated to have good reliability and validity (Chaytor & Schmitter-
Edgecombe, 2007) and has been extensively used in other neurological populations (e.g. 
Traumatic Injury). 
Proxy Measures 
Proxy measures were completed by a participant’s family member or close friend. They were 
asked to complete informant versions of the SFS and the DEX questionnaire, alongside the 
Revised Dyadic Adjustment Scale. Details of which are reported above. The informant 
versions of both measures are identical to the self-rated version, the only exception is that 
there is a couple of questions about employment on the self-report version of the SFS. There 
are no additional psychometric properties reported for the informant measure of either scale.  
 
Procedure 
The study (see Appendix D for protocol) received a favourable ethical opinion from the South 
East Scotland Research Ethics Committee 1 (Appendix E) and site-specific approvals from NHS 
Fife and NHS Lothian Research and Development departments (Appendixes F and G). All 
participants provided informed written consent to participate in the study (Appendixes H and 
I). In addition, each consenting participant was invited to contact a relative or friend who had 
the opportunity to observe everyday behaviour to complete proxy measures, with 27 of the 




Participants were sent the self-report measures, and where appropriate proxy measures, in 
the post for them to complete at home prior to their scheduled appointment with the 
researcher to complete neuropsychological testing. Participants were tested individually at 
an outpatient department within NHS Fife or NHS Lothian board areas. The battery of tests 
took between 60 and 90 minutes to complete. Most participants were able to complete the 
test battery in one session, whilst 2 required the testing to be completed over 2 shorter 
sessions. This was either due to participant’s time restraints or fatigue. To reduce any order 
effects and limit the impact of fatigue on test performance, the administration order of the 
tests was varied across participants, through a simple rotation of test order.  
 
Data Analysis  
 
Statistical analyses were performed using SPSS software (Version 22.0, IBM Corp., Armock, 
NY, USA). Graphs were used to identify any significant outliners and any typographical errors 
with data input. Descriptive statistics are reported as means ± SD. Pearson’s correlations were 
preformed within the whole sample to explore relationships between demographic variables 
(e.g. individuals time since diagnosis, age, years in education and physical ability index) and 
TOM abilities, to identify if they had any effect on TOM abilities. Mann-Whitney U tests were 
used to explore differences in TOM abilities by gender and MS diagnosis type. Only RRMS and 
SPMS were included in this analysis as only one participant had a diagnosis of benign MS. 
Non-parametric analyses were used due to the sample being subdivided into smaller groups 
and the variables not being normally distributed. 
 
Exploratory Pearson’s correlations explored relationships between TOM, executive 
functioning scores and outcome variables measured by the standardised questionnaires. As 
several of the outcome variables were reported by both the participant and their significant 
other, Wilcoxon tests were used to detect any differences in reporting of psychosocial 
outcomes. The outcome of the Wilcoxon tests was used to determine whether further 
analyses were required to analyse these variables separately, or if separate comparisons were 
not required (e.g. if reports were not significantly different).  
 
Further exploratory analyses were completed to investigate the relationship between TOM 
abilities and psychosocial outcomes through applying linear regression models. Regression 
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model predictors were entered for specific outcome variables based upon the outcomes of 
the Pearson’s correlations between TOM, executive functioning and outcome variables, and 






Descriptive Statistics  
Of the 36 individuals who participated, 27 had a diagnosis of RRMS, 8 SPMS and 1 Benign MS. 
There were 29 females and 7 males; the mean age was 45.53 ± 9.23; the mean years in 
education was 15.89 ± 4.17; mean EDSS (Expanded Disability Status Scale, a measure of 
disability in MS) was 4.24 ± 1.54; mean time since diagnosis was 9.39 years ± 8.39). 
 
Descriptive statistics for each measure and comparisons with normative data are reported in 
Table 1. Individuals did not display impairments on the TOM or executive functioning 
assessments. Additionally, they reported subclinical levels of depressive symptomology, 
better social functioning and fewer dysexecutive behaviours than non-clinical adult samples. 
 
Table 1: Comparisons between MS psychometric test and self-report questionnaire scores 
with normative data sample 
a= Baron-Cohen et al. (2001), b= two citations for test do not report appropriate control group (no control in Stone et al., (1998) and older control 
group (m=57.1±5.1 years) in Gregor et al., (2002) paper) c= Wechsler, (2011), d= Delis et al. (2001), e= Burgess & Shallice (1997), f=original test did 
not have control group complete DEX, therefore, therefore normative data taken from Chan, (2001), g= Beck et al. (1996), h= not able to report as 
measure designed for MS sample specifically, i= Busby et al., 1995, j= Birchwood, et al. (1990) 
Measure Sample Scores 
(m± SD) 
                                            Normative data 
Score classifications (m± SD) Normative Group 
RMET 25.36 ±5.43 26.2 ±3.6 Adults, adult students and IQ- matched controls 
(n=205)a 
Faux Pas 5.36 ±2.54 N/Kb  
TOPF IQ= 104 ±8.48 IQ=100 ±15 Adults demographically matched to census data 
(n=248)c  
Verbal Fluency SS= 10.03 ± 3.59 SS=10 ±3 Non-clinical adults (n=1050)d 
Category Fluency SS= 11.22 ± 3.61 SS=10 ±3 Non-clinical adults (n=1050)d 
Switching Fluency SS= 11.44 ±4.44 SS=10 ±3 Non-clinical adults (n=1050)d 
Hayling  6 ±1.22 Average range Non-clinical adults (n=121)e 
Brixton  6.97 ±2.15 Average-high average range Non-clinical adults (n=121)e 
DEX Questionnaire 19.75 ±14.33 22.13 ±8.86  Non-clinical individuals- no history of head injury, 
central nervous diseases or mental illness (n=93)f 
BDI 13.89 ±9.57 Minimal symptoms Hospital/clinic outpatients (n=500)g 
MS QoL- Physical Health 52.21 ±.46 h  
MS QoL- Mental Health 66.03 ±20.59 h  
RDAS 48 ±11.42 52.3 ±6.6 Non-clinical couples, scoring up 107 on dyadic 
adjustment Scale (n=144)i 
SFS Withdrawal 110.8 ±13.40 100 ±15 Non-clinical sample recruited through relatives of 
individuals with schizophrenia (n=100)j 
SFS Interaction 132.88 ±16.67 100 ±15 Non-clinical sample recruited through relatives of 
individuals with schizophrenia (n=100)j 
SFS Performance 116.38 ±12.72 100 ±15 Non-clinical sample recruited through relatives of 
individuals with schizophrenia (n=100)j 
SFS Competence 113.66 ±10.77 100 ±15 Non-clinical sample recruited through relatives of 
individuals with schizophrenia (n=100)j 
SFS Recreation 117.20 ±15.30 100 ±15 Non-clinical sample recruited through relatives of 
individuals with schizophrenia (n=100)j 
SFS Prosocial 115.29 ±12.36 100 ±15 Non-clinical sample recruited through relatives of 
individuals with schizophrenia (n=100)j 
SFS Employment  110.62 ±12.59 100 ±15 Non-clinical sample recruited through relatives of 




 Relationships between demographic variables and TOM abilities 
Pearson’s correlations between scores on the RMET and: age, EDSS score, years in education 
and time since diagnosis were all non-significant, p ranging from .096- .539 (Table 2). The faux 
pas test negatively correlated with age and positively with years in education. Faux pas test 
performance was not significantly associated with time since diagnosis or EDSS scores (Table 
2).  
 
On the RMET, women’s (mean= 26 ±5.68, Mdn=27) performance did not significantly differ 
from men’s (mean= 22.71 ±3.4, Mdn= 22) performance (U= 63, z= -1.55, p= .131, r= .257). 
Similarly, on the faux pas test there was no significant difference (U= 57, z=-1.783, p= .078, r= 
-.300) between female (mean= 5.69 ±2.42, Mdn= 6) and male (mean= 4 ±2.77, Mdn= 4) 
participants’ performance. Performance on the RMET did not significantly differ across 
diagnosis types (U= 61, z= -1.851, p= .064, r= -.313), RRMS (mean= 26.41 ±5.19, Mdn= 27) and 
SPMS (mean= 22.25 ±5.50, Mdn= 22). Similarly, scores on the faux pas test (RRMS (mean= 
5.78 ±2.38, Mdn= 6), SPMS (mean= 3.88 ±2.85, Mdn= 3.50)), did not significantly differ by 
diagnosis type (U=64.5, z= -1.721, p= .085, r= -.291).  
 
Table 2: Correlations between TOM ability and demographic variables 
 RMET Faux Pas  
r p r p 
Age -.158 .192 -.511 .001 
EDSS -.282 .096 -.277 .101 
Years in Education .161 .349 .408 .014 
Time since diagnosis  .106 .539 -.134 .436 
 
Relationships between TOM and cognitive abilities, and psychosocial outcomes 
Individuals’ performance on the two measures of TOM did not significantly correlate with one 
another (r= .214, p= .211). Performance on the RMET was significantly related to an 
individual’s estimated IQ (r= .336, p= .045), verbal fluency (r= .441, p= .008) and switching 
fluency (r= .443, p= .007), whilst performance on the faux pas test significantly correlated with  
estimated IQ (r= .363, p= .029), Hayling (r= .332,  p= .048), Brixton (r= .458, p= .005), verbal 
fluency (r= .414, p= .013), category fluency (r= .592, p= .000) and switching fluency (r= .474, 
p= .003) scores. Performance on the RMET was not correlated with any of the participant 
reported outcome variables (p ranged from .063- .942), however, faux pas performance was 
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significantly related to participants’ reported social withdrawal (r= .355, p= .036), 
employment (r= .475, p= .005) and physical health related quality of life (r= .405, p= .014). 
There was no significant difference in scores reported on all dual rated (participant and 
significant other) outcome measures: the RDAS (T= 132, p= .606, r= -.072), DEX (T= 237, p= 
.244, r= .159) or the seven SFF subscales (p ranges from .234- .954). 
 
Regression Analyses 
Three exploratory regression models were run, one for each of the three outcome variables 
which significantly correlated with Faux Pas performance (Table 3). There were seven 
predictors within each model: faux pas, TOPF, verbal fluency, category fluency, switching 
fluency, Hayling and Brixton scores.  
 
The first model, which explored the relationships between TOM and cognitive abilities and 
social withdrawal, was non-significant (F(7,26)= 2.316, p= .056). Similarly, a regression run to 
predict employment social functioning scores based on TOM and cognitive abilities was non-
significant (F(7, 24)= 2.312, p= .059). Finally, the model calculating physical health related 
quality of life based on TOM and cognitive abilities was significant (F(7,27)= 2.772, p= .026), 
with the predictors explaining 41.8% of the variance in this outcome. However, TOM was not 
a significant predictor (p=.366), with the only significant predictors in this model being verbal 
(p= .036) and switching fluency (p= .034) scores. 
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Table 3: Linear regression model results 
Variable  SFS Withdrawal SFS Employment Physical Health QoL 
B SE Beta t p B SE Beta t p B SE Beta t p 
Faux Pas .397 1.159 .073 .343 .735 1.208 1.071 .246 1.128 .270 1.600 1.741 .191 .919 .366 
TOPF -.205 .300 -.118 1.686 .499 .187 .292 .122 .639 .529 .153 .440 .061 .346 .732 
Verbal Fluency -.351 .837 -.092 -.420 .678 -.843 .765 -.246 -1.102 .281 -2.803 1.269 -.468 -2.209 .036 
Category Fluency -.528 .874 -.143 -.604 .551 .684 .799 .205 .856 .400 .690 1.339 .117 .516 .610 
Switching Fluency  1.333 .713 .442 1.871 .073 .962 .699 .309 1.376 .182 2.344 1.050 .486 2.233 .034 
Hayling 3.558 1.883 .328 1.891 .070 1.200 1.742 .123 .689 .497 3.047 2.867 .175 1.063 .297 
Brixton 1.239 1.145 .190 1.082 .289 .292 1.051 .051 .278 .784 .928 1.733 .091 .536 .596 
(Constant) 94.595 31.658  2.988 .006 65.148 30.524  2.134 .043 -2.101 46.141  -.46 .964 











This study aimed to explore the associations between TOM abilities and psychosocial 
outcomes in individuals with MS. Comparisons made between scores on all TOM and 
executive functioning tasks with normative data gathered from non-clinical adult samples, 
suggested that these abilities were not impaired in the current MS sample. Similarly, when 
comparing self-reported scores on psychosocial questionnaires with test normative data from 
control samples, no difficulties were identified on any subscale of the SFS, depressive 
symptomology was in the non-clinical range, and fewer dysexecutive behaviours were 
reported than in a control sample (Chan, 2001). Performance on one of the TOM measures, 
RMET, was not significantly related to any of the psychosocial outcomes, whilst the other 
measure (Faux Pas test) only correlated, with weak to moderate effect, to three of the 
psychosocial variables. Specifically, social withdrawal, employment and physical health 
related quality of life. However, regression analyses suggested that these variables (faux pa 
performance and executive abilities) did not explain a significant amount of variance in two 
of these measure scores. As this is an exploratory study, these results should be interpreted 
with caution, as the type one error rate is inflated due to the multiple tests used in the 
analysis. Further studies are required to replicate these findings.  
 
The findings from this study were largely unexpected given the theoretical literature and the 
established links between TOM abilities and psychosocial outcomes in other populations 
(Couture, Penn, & Roberts, 2006; Penton-Voak et al., 2017). However, this may be partially 
explained by the unexpected lack of cognitive impairments and psychosocial difficulties 
reported by the current sample. These impairments/difficulties have been evidenced in 
individuals with MS in previous research (Chiaravalloti & DeLuca, 2008; Cotter et al., 2016; 
Pompeii, Moon, & McCrory, 2005), but the current results suggested no impairments, or 
better psychosocial outcomes than control samples. Through considering effect sizes, 
correlation coefficients and r squared values it is unlikely that the lack of reported difficulties 
and significant effects found can primarily be explained by the study being underpowered. 
Most effect sizes were small (<.300), therefore would not be greatly sensitive to change with 




Whilst it is possible that the results are a true reflection of no impairments or associations 
between variables being present, there are an additional three main factors to consider when 
interpreting the results: the sample recruited, the assessment measures used, and analyses 
conducted. The sample was recruited through signposting from clinicians and also through a 
research database and website, with the majority being recruited from the latter. This may 
have biased the sample by predominately attracting individuals with higher education 
qualifications, an interest in academia and taking part in research. In comparing the current 
sample demographics with those included in previous research where TOM impairments 
were identified (e.g. Chanial et al., 2020; Henry et al., 2011; Ouellet et al., 2010; Raimo et al., 
2017), the current sample averaged two or more years extra in education. It is thought that 
greater cognitive abilities prior to a diagnosis of a neurological condition are somewhat 
protective in the slowing of neurological deterioration (Sumowski et al., 2014). This, alongside 
the large cognitive demands of participating in this study may have recruited a sample of 
individuals with less significant cognitive difficulties. However, in contradiction, the sample 
did not include individuals who were within two years of receiving their diagnosis and there 
were no individuals with PPMS, but a large subgroup of the sample was individuals with SPMS, 
who more frequently report cognitive impairments (DeLuca et al., 2004). Therefore, a larger 
spread of cognitive difficulties would have been expected than was seen.  
 
Based on the knowledge that executive functioning may impact upon TOM task performance 
(Henry et al., 2009), the decision was made to include executive measures in the study.  
Unfortunately, given the already high task burden on individuals, further tests exploring a 
wider range of cognitive abilities were not included. This information may have been 
informative and allowed for a more complete and comprehensive understanding of the 
cognitive profiles of the individuals included in the study. It would be interesting for future 
research to consider other cognitive abilities such as attention and processing speed. 
 
A further consideration is the ability and sensitivity of the assessments used to measure the 
constructs they are intended to measure. There remains a lack of research into the reliability, 
validity and suitability of TOM measures use in individuals with MS (Gibson et al., 2020). 
Whilst the TOM measure selection for this study was based upon their psychometrics 
properties in other samples and prior use with individuals with MS, it is possible that they are 
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not sensitive enough to identify subtle difficulties within an MS samples. This is one potential 
explanation for the similarity in RMET scores between this sample and the normative data 
sample. Further work is essential to better understand the suitability of TOM measures more 
generally for use with individuals with MS so these abilities can be accurately measured and 
better understood. Similarly, some of the psychosocial outcome measures (e.g. the RDAS and 
SFS) have not been used with individuals with MS. Given the novel nature of the research 
questions addressed by this study within an MS sample, it was challenging to identify 
appropriate measures and again this was based upon psychometric properties within non-
neurological, non-clinical samples. This makes it challenging to judge whether the current 
reports are a true reflection of the psychosocial characteristics of the sample, or the measures 
used.    
 
Finally, in understanding the findings, the analyses run need to be considered. The 
exploratory nature of this paper resulted in multiple analyses being run to explore the 
associations between a large variety of variables. Therefore, the results need to be considered 
with caution given that associations may be overestimated, and it was not possible to 
accurately calculate the family-wise error rate. Additionally, the limitations of the regression 
analysis are recognised. Given the large number of potential predictors and small sample size, 
the correlation analyses were used, alongside theoretical knowledge of executive 
contributors to TOM performance, to inform predictor input. It is recognised that predictor 
selection through this means can be challenging as the relationship between predictors and 
outcomes varies upon the other predictors in the model (Field, 2013, p.323). Whilst one 
model (physical health QoL) came out significant and the other two near significance, it is 
possible that the model fit, and estimates were influenced by the large predictor to 
participant ratio. This is emphasised by the lack of significant relationships for single 
predictors within the model and low R2 values considering the number of predictors. Whilst 
the sample size was similar to that used in other studies in this research area, further research 
using a larger sample is required to better understand the associations between these 
variables.  
 
Additionally, the smaller than desirable sample size had implications when interpreting the 
analyses exploring subtype and gender variations in TOM abilities. The effect sizes suggest 
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that the analyses have likely been impacted by low power and therefore it is not possible to 
reliably conclude that there is no difference across subtypes or genders. It would be 
informative for further research to be completed to explore any variations in TOM and/or 
cognitive abilities, and their associations with psychosocial outcomes across gender and MS 
subtypes.  
 
In conclusion, this study aimed to explore the associations between TOM abilities and several 
psychosocial outcomes in individuals with MS. However, within the current sample TOM 
impairments and psychosocial difficulties were not commonly reported, similar to previous 
research and limited relationships between variables found. However, initial findings suggest 
there may be links between TOM abilities and some areas of social functioning, in individuals 
with MS. Future confirmatory studies should aim to explore this hypothesis in larger, and 
more cognitively diverse samples. Additionally, it is recommended that research into the 
psychometrics and suitability of TOM measures within this population is conducted, to ensure 
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Appendix C: Sample Items from the Faux Pas Test (Baron-Cohen et al., 1999; Stone & Baron-
Cohen, 1998) 
 














Faux Pas Recognition Test           Valerie E Stone 
© 1998  Simon Baron-Cohen 
4 
Story 2. Helen's husband was throwing a surprise party for her birthday. He invited Sarah, a friend 
of Helen's, and said, "Don't tell anyone, especially Helen." The day before the party, Helen was over 
at Sarah's and Sarah spilled some coffee on a new dress that was hanging over her chair. 
"Oh!" said Sarah, "I was going to wear this to your party!"  
"What party?" said Helen. 




1.  Did anyone say something they shouldn't have said or something awkward? 
 
If yes, ask: 
 


















5.  Did Sarah remember that the party was a surprise party? 
 
 









8.  What got spilled on the dress? 
  
   
Faux Pas Recognition Test           Valerie E Stone 
© 1998  Simon Baron-Cohen 
9 
Story 7. Sally is a three-year-old girl with a round face and short blonde hair. She was at her Aunt 
Carol's house. The doorbell rang and her Aunt Carol answered it. It was Mary, a neighbour.  
"Hi," Aunt Carol said, "Nice of you to stop by."  





1.  Did anyone say something they shouldn't have said or something awkward? 
 
If yes, ask: 
 


















5.  Did Mary know that Sally was a girl? 
 
 
6.  How do you think Sally felt? 
 
 




8.  Who came to visit? 
  
   
Faux Pas Recognition T st           Valerie E Stone 
© 1998  Simon Baron-Cohen 
3 
Story 1. Vicky was at a party at her friend Oliver’s house. She was talking to Oliver when another 
woman came up to them. She was one of Oliver’s neighbours. The woman said, "Hello," then 
turned to Vicky and said, " I don't think we've met. I’m Maria, what's your name?"  
"I’m Vicky." 




1.  Did anyone say something they shouldn't have said or something awkward? 
 
 
If yes, ask: 
 


















5.  Did Vicky and Maria know each other? 
 
 









8.  Who was hosting the party? 
Faux Pas Recognition Test           Valerie E Stone 
© 1998  Simon Baron-Cohen 
11 
Story 9. Joanne had had a major role in last year's school play and she really wanted the lead role this 
year. She took acting classes, and in the spring, she auditioned for the play. The day the decisions 
were posted, she went before class to check the list of who had made the play.  
She hadn't made the lead and had instead been cast in a minor role. She ran into her boyfriend in the 
hall and told him what had happened. "I'm sorry,” he said. "You must be disappointed."  




1.  Did anyone say something they shouldn't have said or something awkward? 
 
If yes, ask: 
 
2.  Who said something they shouldn't have said or something awkward? 
 
























8.  What kind of role had she had the previous year? 
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Appendix D: Study Protocol 
 
Study Protocol 
Psychological, Interpersonal and Social Functioning in MS:  







 The University of Edinburgh  
College of Arts, Humanities and Social Sciences 
55 George Square 
Edinburgh 
EH8 9JU 
Protocol authors Rachel Gibson  
Chief Investigator Rachel Gibson (Trainee Clinical Psychologist)  
Sponsor number CAHSS1809/07 
REC Number RECSES01 19/SS/0006 
Version Number and Date Version 2, 10/02/2019  
Amendment classification and 
number: 
Summary of change(s) 
Version 2 Following attending SESREC01 the protocol was updated to: 
detail that individuals would be offered breaks and 
refreshments; report total study commitment time; and that 
sealed, addressed envelopes will be provided. Additionally, the 
recruitment protocol for NHS Lothian was changed to be 
similar to that of NHS Fife. 
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Multiple Sclerosis  
Multiple Sclerosis (MS) is the most common cause of neurological disability in young people in the UK 
(MS Society, 2018), with around 100,000 individuals having a diagnosis of MS. MS is a chronic, 
inflammatory disease of the central nervous system, characterised by demyelination (Feinstein, 2007). 
 
MS is a heterogeneous condition with symptoms varying depending upon the location and extent of 
the myelin damage (Feinstein, 2007). Symptoms also vary by MS subtype, with each subtype being 
characterised by a different disease course. The most prevalent subtype is relapse-remitting MS 
(RRMS), which approximately 85% of individuals are initially diagnosed with. Individuals with RRMS 
experience acute relapses characterised by neurological deterioration, followed by a period of (full or 
partial) recovery (Feinstein, 2007). Between relapses their presentation remains stable. Some 
individuals with RRMS will later develop secondary progressive MS (SPMS), which is characterised by 
progressive deterioration, with or without the relapses.  Alternatively, around 15% of individuals are 
initially diagnosed with primary progressive MS (PPMS), which is characterised by gradual, continuous 
deterioration in neurological functioning (Feinstein, 2007), with no acute relapses. Similar to RRMS, 
many of these individuals will go onto develop SPMS. Whilst previously research into symptomology 
in MS has focused on physical symptoms, more recently cognitive symptoms have been gathering 
more interest (Niino, 2016b).  
 
Cognitive Functioning in MS 
Demyelination leads to a slower transmission of electrical signals between neurons in the brain, and 
if demyelination continues it can progress to axonal damage (Feinstein, 2007). Given that neurological 
damage is present in all individuals with MS, they are more vulnerable to developing 
neuropsychological impairments. Research has shown that neuropsychological impairments are 
common in individuals with MS, with up to 70% of individuals displaying some form of cognitive 
impairment (Cotter et al. 2016). Whilst cognitive dysfunction has been shown in all MS subtypes, the 
extent of this is thought to vary by MS subtype. For example in one study, individuals with RRMS have 
been shown to experience greater cognitive impairments than individuals with PPMS (Niino, 2016b). 
Given that cognitive dysfunction has been shown to be a predictor of lower social engagement and 
poorer quality of life in individuals with MS (Niino, 2016b; Sartori & Edan, 2006), it is important that 
all areas of cognitive function are researched and their links to social outcomes are better understood.  
 
Several neuropsychological characteristics in MS are well-established in the literature (e.g.  
impairments in processing speed, working memory, and executive functioning; Bobholz & Rao, 2003; 
Feinstein, 2007; Niino, 2016), however, less research has explored the sixth core domain of 
neurocognitive functioning (Henry, et al. 2015), social cognition (SC; Cotter et al. 2016). SC refers to 
the ‘mental operations that underlie social interactions’ (Cotter et al. 2018) and is an umbrella term 
for a number of cognitive abilities including emotion recognition, theory of mind (TOM), and empathy 
(Lysaker et al. 2014). As SC impairments have been linked to the development and maintenance of 
mental health concerns (Penton-Voak et al. 2017), it is important more research explores these 




Social Cognition/ Theory of Mind in MS  
There is consistent evidence of SC impairments in individuals with MS, across a range of SC abilities 
(see Gleichgerrcht et al. 2015; Henry et al. 2011; Lenne et al. 2014; Ouellet et al. 2010; Phillips et al. 
2011). One of the most researched SC abilities is theory of mind (TOM), which refers to an individual’s 
ability to attribute the mental states of oneself and others (e.g. their beliefs, goals, intentions and 
emotion; Banati et al. 2010) which is crucial in both understanding and predicting behaviour. Research 
into TOM in individual’s with MS has consistently shown this ability to be impaired when compared 
against healthy controls. Specifically, a recent meta-analysis (Cotter et al. 2016) which explored TOM 
and emotion recognition abilities in individuals with MS, found both to be impaired when compared 
against healthy controls. The magnitude of these impairments was either equivalent to or greater than 
other cognitive domains (e.g. memory, language and planning).  
 
Whilst the magnitude of SC impairments has been explored in individuals with MS, there has been 
very little research exploring the impact of these SC deficits on an individual’s functioning (Henry et 
al., 2011). One study which explored emotion perception deficits in MS (Phillips et al., 2011) found 
associations with reduced psychological and social quality of life. Whilst there has been limited 
research exploring the relationship between TOM and depressive symptomology in individuals with 
MS, no relationship has been found (Cotter et al. 2016). To the researcher’s knowledge, there has 
been no similar research exploring the relationship between TOM and interpersonal or social 
functioning. Given that there are many social (e.g. isolation, reduced independence) and cognitive 
(e.g. slower processing speed, impaired TOM) symptoms commonly seen in individuals with MS 
(Feinstein, 2007), it is surprising that the relationships between these have not been explored. 
Additionally, given that TOM is an important skill required for engaging in social interaction and 
adapting behaviour to our environment, it is possible that impairments in TOM abilities mat be 
partially associated with the poorer relationship quality and lower quality of life in individuals with MS 
(Henry, Tourbah, Chaunu, Bakchine, & Montreuil, 2017). This study aims to explore this relationship, 
which may be informative in improving the clinical management and rehabilitation interventions 
available to individuals with MS.  
 
Given that RRMS is initially the more prevalent MS subtype (Feinstein, 2007), it is not surprising that 
to date, the majority of research into SC in MS has recruited primarily individuals with RRMS. 
Specifically, data from a recent meta-analysis (Cotter et al., 2016) highlighted that 77% of all 
participants in SC research had a RRMS diagnosis, with the remaining 23% having an alternative MS 
diagnosis.  Therefore, little is known about the homogeneity of TOM impairments across MS subtypes. 
Given that individuals with RRMS have been shown to have greater cognitive impairments than 
individuals with other MS diagnoses (Niino, 2016b), there is reason to suggest that TOM impairments 
may not be homogenous across MS subtypes either. To date, no study has been able to make any 
comparisons (even exploratory) on TOM abilities across MS subtypes. This would be a valuable 
addition to the research base (Phillips et al., 2011), to help better understand the varying clinical 
presentations of MS subtypes.   
 
It is well known that greater pre-exist cognitive abilities (cognitive reserve) are a protective factor 
against cognitive dysfunction (Sumowski & Leavitt, 2013). A one year longitudinal study showed 
cognitive and brain reserve (brain mass) were protective factors for both memory and processing 
speed in individuals with MS (Sumowski et al. 2014). Whilst a recent pilot study (N=15) found a positive 
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relationship between cognitive ability (IQ) and performance on a SC test battery in individuals with 
MS (Genova, et al. 2016), this relationship has not been explored on other measures of SC or replicated 
on a larger sample.  
 
TOM Based Interventions 
There has been some promising findings for TOM based interventions in other clinical populations 
(Kurtz, et al. 2016), primarily individuals with schizophrenia. Kurtz et al. (2016) also specifically 
explored the effectiveness of TOM based interventions across 13 studies, with 10 evidencing positive 
improvements following intervention (Cohen’s d=0.7), including improved TOM and social 
functioning. There is currently no research on TOM interventions within a MS population. This may 
partly be explained by the limited TOM research and remaining gaps in the knowledge base for 
individuals with MS. The current study hopes to address some of these gaps, which is required prior 
to future work exploring possible interventions for SC impairments in individuals with MS. 
 
Rationale for Study 
Whilst research has highlighted impaired TOM (Cotter et al., 2016), impaired social functioning 
(Feinstein, 2007), reduced quality of life (Phillips et al., 2011) and reduced relationship quality (King & 
Arnett, 2005) in individuals with MS, no study has explored the relationships between these variables. 
Given that TOM is important for effective social interactions and adapting behaviour appropriately to 
an audience, it is possible that impairments to TOM are associated with the lower relationships quality 
and quality of life reported in individuals with MS. This is a significant gap in the existing knowledge 
base as without fully understanding the links between neuropsychological and psychosocial variables 
in individuals with MS, it is not possible to ascertain which areas of functioning rehabilitation 
interventions should focus on. Whilst this study does not aim to explore or evidence TOM 
interventions, it is hoped that thought aiming to explore any possible relationship between TOM and 
social, emotional and interpersonal functioning we can inform future research into potential 
interventions and enhance clinical management of this population.  
 
Additionally, the majority of research to date has explored TOM abilities in individuals with RRMS, 
however, there is research to suggest there may be differences in cognitive impairments across 




• Is Theory of Mind associated with psychological, social and interpersonal functioning in 
individuals with Multiple Sclerosis (MS)? 
Secondary Objectives 
• Is there a difference in TOM performance across different MS subtypes? Specifically, 
Relapse-Remitting MS and Primary Progressive MS.  
• Is there a relationship between estimated cognitive abilities pre-diagnosis and TOM abilities 





The study will use a questionnaire based, within-group design. This particular design was chosen 
because impairments in Theory of Mind (TOM) in individuals with MS have been consistently shown 
in the literature by comparing test performance with individuals without MS (between-group studies), 
therefore it was not felt necessary to further replicate this here. The study will implement a cross-
sectional design as the primary aim is to explore the relationships between TOM and other functional 
abilities, rather than to explore the trajectory of impairments over the disease course.  As this is a 
student project, the project will be completed, and written up ahead of May 2020.  
 
Procedure 
Potential participants will be identified using methods described below (see section 5.1). Potential 
participants will either consent to the research team contacting them by phone or they will call into 
the research team themselves. During the initial phone call, the potential participant will have the 
opportunity to ask any questions they may have about the project, the PI will gain verbal consent from 
the individuals if they wish to participate and arrange an appointment for the individual to attend to 
complete the neuropsychological assessments. 
Participants will be sent out several self-report questionnaires in the post, which they will be asked to 
complete at home prior to attending their assessment appointment. If they forget to complete these, 
they will have the opportunity to complete them when they attend for their appointment or they will 
be sent home with a stamped addressed envelope to return them in. Additional to the self-report 
questionnaires, there are a few questionnaires which require a significant other to complete (e.g. 
family or friend). During the initial phone call, consent will be sought from participants for these 
measures to be sent out. If the participant consents to these measures being completed, they will be 
sent out alongside the participant’s self-report measures, for the participant to distribute to the 
appropriate person to complete. These will either be returned when the participant attends for their 
assessment appointment, or they can be returned in the stamped addressed envelope provided. If 
these are not returned at this time, the participant will be reminded of these and asked for them to 
be completed and returned.   
The participant will be required to attend one 90-minute assessment appointment, during which all 
neuropsychological assessment measures will be completed. As individuals with MS can experience 
fatigue, this will be monitored by the PI during the appointment, through direct questioning and 
observation of behaviour and body language. If required they will be able to take a break during 
testing, when refreshments can be provided, or testing can be completed over multiple sessions, to 
reduce participant burden and limit the impact of fatigue on test performance. Additionally, to 
distribute the potential impact of fatigue across the various measures, the order of the tests will vary 
across participants, with the tests continually rotating in order of presentation with each participant. 
This will also limit the possibility of any order effects.  
The appointments will be held within outpatient hospital clinics and GP practices within the 
participant’s NHS board area. Where possible in NHS Fife, the appointment will be offered with the 
participants preferences (location/time) in mind. In NHS Lothian, appointments will be primarily held 
at the Anne Rowling Clinic. At this appointment, before testing has commenced, written consent will 
be obtained from all participants. Individuals will then be asked to complete a battery of 
neuropsychological tests, which will assess their TOM and their executive abilities (e.g. attention, 
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planning, problem solving). The specific tests/measures/questionnaires are detailed below (see 
section 6).  
Participants are only required to attend one appointment and therefore at most, participants will be 
involved in the study for a few months. However, study duration will be dependent upon the individual 
and PI’s availability and when an assessment appointment can be booked in.  
 
Study Participants  
 Number of Participants 
The required sample size was determined using the primary research objective, which will be 
answered using regression analysis. The G*Power programme (Faul, Erdfelder, Buchner, & Lang, 2009) 
was used to calculate sample size. For a multivariate linear regression, with three predictor variables, 
a sample size of 61 is required. Power was set at 0.8, alpha at 0.017 (to control for multiple 
comparisons) and the effect size was set as medium. Through reviewing previous research which has 
explored SC in individuals with MS, medium to large effect sizes have been shown in studies which 
have primarily aimed to explore the magnitude of SC impairments within this population (see Cotter 
et al. 2016; Genova et al. 2016; Phillips et al. 2011). Taking this into consideration, alongside the lack 
of research into the impact of impaired SC on functional abilities, the effect size was set as medium. 
The study aims to recruit from two sites: Fife Rehabilitation Service (NHS Fife) and NHS Lothian’s Anne 
Rowling Clinic. It is hoped that they will recruit around 40 and 20 participants, respectively. As this is 
a student project, this places some restrictions on the recruitment window for this project. The PI aims 
to facilitate as long a recruitment window as is feasible, hopefully around 12 months.  
Within NHS Fife, there is a database with over 700 individuals with a diagnosis of MS, who are within 
the specified age category. In NHS Lothian, they see around 50 individuals a week in the MS clinic. 
Staff from both research sites are optimistic about being able to achieve/ recruit the required sample 
size. 
 Inclusion Criteria  
• A pre-existing, formal diagnosis of Multiple Sclerosis (MS) from a neurologist or other medical 
professional. Specifically, the study will aim to recruit individuals who are at least two years 
post diagnosis or have had two relapses (if RRMS).   
o It is hoped that by recruiting individuals who are a 2+ years post diagnosis or have had 
2+ relapses, there will be a greater possibility of recruiting individuals with varying 
degrees of TOM impairments. Additionally, in the earlier stages of the disease course, 
an individual’s cognitive functioning may be less stable; they may be adjusting 
psychologically and emotionally to receiving their diagnosis; as well as beginning 
treatment (e.g. modification therapy). Therefore, those who have recently been 
diagnosed will not be considered for recruitment.  
• Aged between 18 and 65 years. MS is typically diagnosed between 20 and 40 years of age.  
o As individuals under the age of 18 years may represent a different clinical population, 
they will not be recruited into the study.  
o Due to time constraints, it is not possible for the study to screen individuals for 
cognitive decline. Whilst the research team recognises that not all individuals over 65 
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years will experience cognitive impairment, the age cut-off minimises the risk of age-
related decline acting as a confounding variable. 
 Exclusion Criteria  
The exclusion criteria listed below will be considered when recruiting all potential participants into 
the study. Information related to the exclusion criteria will be gained through information held in the 
database and/or the individual’s medical records. If the information is not available through theses 
means, the PI will ask and gather this information prior to completing testing. In ambiguous situations, 
decisions on excluding participants will be discussed in supervision with the field supervisor.  
• Individuals for whom English is not their first language  
o As the psychometric tests used within this study were normed on an English-
speaking population, the norms would not be representative or appropriate for use 
with individuals for whom English is not their dominant language. 
• Individuals who are unable to provide informed consent.  
o It is possible that individuals who are unable to provide informed consent may have 
significant cognitive impairments. Taking this into consideration, the testing 
environment would likely be both challenging and distressing for them, therefore, it 
would be unethical to include them in the test sample. 
• History of substance misuse.  
o Substance misuse is known to impact upon an individual’s thinking, problem solving 
and perception (American Psychiatric Association, 2013). Therefore, it would not be 
possible to ascertain whether any cognitive impairment was due to substance misuse 
or a product of their MS.     
• Diagnosis (current or historical) which affects social or cognitive functioning (e.g. Autism 
Spectrum Disorder, Brain Injury, Dementia, Learning Disability, Psychosis).  
o As the above conditions are known to affect cognitive and social functioning, it would 
not be possible to fully understand the contribution of an individual’s MS on their 
functioning in isolation of the cognitive and social impairments of the above 
conditions.  
• Current or historic severe aphasia.  
o As several of the psychometric tests used in this study rely on verbal responses, 
individuals with aphasia will not be included as their aphasia would likely influence 
test performance.  
• Individuals with significant hearing or visual impairments which would impact on their ability 
to adequately complete testing. 
o Similar to reasons detailed above, any visual or hearing impairment may impact upon 
test administration and subsequently test performance. Unfortunately, it is not 
possible for tests to be adapted as this may confound the results. 
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Participant Selection and Enrolment  
NHS Fife 
Within the Fife Rehabilitation Service (NHS Fife), potential participants will be identified from an 
existing database, which holds data on over 700 individuals with an MS diagnosis. This database is 
owned and managed by one of the MS Nurses within the team, and they have consent to contact 
individuals contained within the database for research purposes. This individual will be responsible 
for identifying potential participants at this site. Individuals who have been more recently seen in the 
service, who meet the inclusion criteria, will be invited to participate initially. This is because on the 
database their information will be the most up to date and more representative of their current 
presentation. Should too few individuals opt in to participating, additional invites will be sent out, 
working backwards chronologically from their discharge date. Potential participants will be sent a 
letter from the MS nurse which will include a reply slip for them to complete and return to her should 
they wish to participate in the research study. They can also phone the PI directly. If participants do 
not wish to participate, they are encouraged to inform the MS nurse, to prevent them receiving 
further information about the study. 
NHS Lothian 
At the NHS Lothian site (Anne Rowling Clinic), potential participants will be identified by their 
neurologist or MS nurse during clinic appointments. Potential participants will already be enrolled 
with ‘Rowling Care’, which is a register of individuals known to the Anne Rowling Clinic who are willing 
to be contacted about ongoing research. When an individual who is registered with Rowling Care and 
meets the inclusion criteria for the study, attends for a clinic appointment they will be informed by 
the clinician (neurologist or MS nurse) about the study and given a participant information sheet and 
letter of invitation. Individuals will be able to express an interest in the study in two ways. Specifically, 
they will be able to inform the clinician at the clinic or if the individual requires additional time to 
consider their participation, they will be able to return a reply slip attached to the bottom of the letter 
of invitation to the neurologist from the clinic. Their details will then be given to the PI who will contact 
them to discuss participation, answer any questions they have and arrange an appointment for 
neuropsychological testing.  
  Consenting Participants  
Only individuals who are able to provide informed consent will be invited to take part in the study. 
The decision on whether an individual has capacity will be determined by the most recent assessment 
made by an individual from the participants direct care team. Particularly at the NHS Lothian site, the 
direct care team will be identifying potential participants for the study, therefore, an individual’s 
capacity will be considered at this point. In NHS Fife, this will be a previous or current member of the 
individual’s care team. 
Potential participants will initially be sent out or given a written information sheet about the study 
and given the opportunity to consider whether they wish to take part. In NHS Fife, as information will 
be sent in the post, there will be no formally specified time period for them to consider their decision. 
As individuals with MS can experience relapse, this may impact their ability to take part (during and 3 
months post relapse), however, once their functioning has stabled they may wish to participate. 
Therefore, by not specifying a time frame this allows the individual to consider participating when 
their health allows them to. In NHS Lothian, individuals will be able to consider participation until their 
follow-up clinic appointment. It is unlikely that past this point that individual will opt in as their follow-
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up appointment would allow them to ask questions and be directed to the PI to answer these. The 
recruitment window for this study will be approximately one year, due to it being a student project. 
Only towards the end of this period may the time allocated for the potential participant to consider 
their decision be more limited. 
Once potential participants have had the time to consider their decision, they will then either call the 
PI to express interest or will be called by the PI if they have informed another clinical member of staff 
that they wish to participate. At this point verbal consent will be gained over the phone by the PI and 
an appointment arranged with the participant for them to attend to complete the neuropsychological 
testing. At this appointment, the PI will provide the potential participant with the opportunity to go 
over the participant information sheet and answer any questions they have about participating in the 
study. All questions will be answered and following this, should the potential participant still wish to 
take part, a written consent form will be completed. 
Withdrawal of Study Participants 
Participants are free to withdraw from the study at any point or a participant can be withdrawn by 
the investigator. For example, if they lose capacity during study or if tasks are too demanding and 
cause them significant distress. The participant will be withdrawn from all aspects of the trial, including 
data gathered up to this point which will not be included in the analysis. 
  
Partners and/or Significant Other  
  Identifying Participants  
As mentioned in section 3.2, participant’s partners and/or significant other will be invited to take part 
in the study. Specifically, this will involve them completing a few questionnaires, which ask about the 
primary participant’s social engagement and the quality of the relationship they have with them.  
Individuals will be identified by the primary participant, the individual with MS. They will be informed 
that the chosen individual should know them well and have regular contact with them. During the 
initial phone call with the primary participant, the PI will: discuss the selection of a partner and/or 
significant other with the primary participant; and go through the inclusion and exclusion criteria to 
ensure the individual selects an individual who meets the criteria. Specifically, the PI will send out a 
participant information sheet and the other-report measures for the significant other, alongside the 
information sent to the primary participant. The primary participant will be asked to distribute the 
information to their partner and or significant other.  
  Inclusion Criteria  
• Will have known the primary participant for at least one year 
• Have regular contact with the primary participant (at least once a week) 
• Be able to provide informed consent 
  Exclusion Criteria  
• Individuals who are unable to comprehensively understand the information contained in the 
questionnaires. For example: individuals with a learning disability or individuals who are not 
fluent in English, as translations cannot be provided.  
• Individuals who are unable to provide informed consent 
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  Withdrawal of Study Participants 
Participants are free to withdraw from the study at any point or a participant can be withdrawn by 
the investigator. For example, if they are unable to understand or complete the measures. The 
participant will be withdrawn from all aspects of the trial, including data gathered up to this point 
which will not be included in the analysis. Their withdrawal will not impact upon the primary 
participant’s involvement in the study.  
 
Study Assessment  
The neuropsychological tests and the questionnaires which the participants will be asked to complete 
are detailed in the table below.  Total commitment time for the primary participants is between two 
hours and two hours fifteen minutes. For significant others, total commitment time is up to thirty 
minutes.  
 
Assessment/questionnaire Description of task Time to 
administer 
Who will administer task and 
where 
Reading the Mind in the Eyes 
Test (RMET).  
 
RMET is a measure of affective TOM. 
The individual is shown 36 sets of eyes 
and have to choose the emotion shown 
by the eyes. 
20 The principal investigator will 
conduct the procedure, in an 
outpatient appointment with 
the individual 
Faux Pas Recognition Test 
 
This is a measure of cognitive and 
affective TOM. The individual is read 20 
stories and asked to identify any faux 
pas. 
20 The principal investigator will 
conduct the procedure, in an 
outpatient appointment with 
the individual 
The Test of Premorbid Function 
(TOPF).  
 
The TOPF is a reading test which aims to 
estimate an individual’s pre-morbid 
cognitive function. The individual is 
required to read 70 words which have 
atypical grapheme to phoneme 
translations 
 
5 The principal investigator will 
conduct the procedure, in an 
outpatient appointment with 
the individual 
Verbal and Category Fluency. 
 
This is a measure of mental flexibility. 
Individuals are given  a letter of the 
alphabet or semantic category and 
asked to generate as many words as 
possible in 1 minute 
15 The principal investigator will 
conduct the procedure, in an 
outpatient appointment with 
the individual 
Hayling Sentence Completion 
Test 
 
This is a sentence completion task.  
Part 1- measures response speed and 
initiation by asking the individual to 
complete a sentence 
10 The principal investigator will 
conduct the procedure, in an 




Part 2- measures response suppression 
by asking the individual to complete the 
sentence but this time with a 
completely unrelated word 
The Brixton Spatial Anticipation 
Test  
This task measures rule detection and 
set shifting. Individuals are shown 10 
circles, one of which is blue. They have 
to predict the location of the blue circle 
on the next page, following set rules. 
15 The principal investigator will 
conduct the procedure, in an 
outpatient appointment with 
the individual 
Beck's Depression Inventory  This is a 21 item, self-report measure of 
depression symptomology. 
5 This will be completed by the 
participants at home, prior to 
attending for the 
neuropsychological testing 
appointment. 
The Multiple Sclerosis Quality of 
Life- 54  
This is a 54 item, self-report measure of 
quality of life. 
10 This will be completed by the 
participants at home, prior to 
attending for the 
neuropsychological testing 
appointment. 
The Social Functioning Scale   This questionnaire assesses social 
functioning. It is specifically designed 
for use in chronic conditions, focusing 
primarily on independence, social 
engagement, friendships and daily 
activities. 
15 This will be completed by the 
participants at home, prior to 
attending for the 
neuropsychological testing 
appointment. It will also be 
completed by a 
friend/relative if available. 
The DEX questionnaire This is a 20 item questionnaire designed 
to assess for behaviours associated with 
dysexecutive syndromes including 
emotional or personality changes, 
motivational changes, behavioural 
changes and cognitive changes. 
10 This will be completed by the 
participants at home, prior to 
attending for the 
neuropsychological testing 
appointment. It will also be 
completed by a 
friend/relative if available. 
The Revised Dyadic Adjustment 
(RDAS)  
This is a 14 item questionnaire which 
assesses relationship quality. 
10 This will be completed by the 
participants at home, prior to 
attending for the 
neuropsychological testing 
appointment. It will also be 
completed by a 
friend/relative if available. 
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Data Collection  
As this study is a cross-sectional study, data will only be collected at a single time point. As detailed 
above, participants will complete a range of standardised assessment measures and questionnaires. 
From all of these measures and questionnaires standardised scores will be generated. All data will be 
collected by the PI. 
 
Where possible, the PI will aim to maximise the completeness of data collection using several 
methods:  
• Participants will be asked to complete questionnaires ahead of their assessment appointment, 
to help distribute and limit the potential test burden on participants. Additionally in doing so, 
a second opportunity (at the testing session) is provided for participants to complete the 
questionnaires and for these to be assessed for missing values by the PI.  
• Where possible, testing will be completed during one session and if the individual appears to 
be experiencing fatigue they will encouraged to take a break. Whilst the PI recognises that not 
all individuals will be able to complete testing in one sitting, this will be completed where 
possible as this would limit the opportunity for participants to drop-out (e.g. not being able 
to or remembering to attend a second appointment). Also, one session places less demand on 
the participants, both placing less pressure on their time and limiting travel costs.  
• Finally, a participant’s significant other will be asked to complete two questionnaires. These 
will also be sent out ahead of the testing appointment as participants will be able to return 
these in person when they attend their appointment, where the PI can check for missing data. 
If they do not return them at this time, the PI will remind the participant about these and 
gather contact details to call them should an additional reminder be required or if measure 
are to be completed over the phone. Only one addition reminder will be given, so as not to 
place too much pressure on the individual to complete them.  
 
  Source Data Documentation  
Source documents include all the record forms for the neuropsychological tests, and all the paper 
questionnaires completed by the participants and their significant others. Additionally, relevant 
sections of the participants medical records will be reviewed.  
 
Statistical and Data Analysis  
 Sample Size Calculation  
The required sample size was determined using the primary research objective, which will be 
answered using regression analysis. The G*Power programme (Faul et al., 2009) was used to calculate 
sample size. For a multivariate linear regression, with three predictor variables, a sample size of 61 is 
required. Power was set at 0.8, alpha at 0.017 (to control for multiple comparisons) and the effect size 
was set as medium. Through reviewing previous research which has explored SC in individuals with 
MS, medium to large effect sizes have been shown in studies which have primarily aimed to explore 
the magnitude of SC impairments within this population (see Cotter et al. 2016; Genova et al. 2016; 
Phillips et al. 2011). Taking this into consideration, alongside the lack of research into the impact of 





The data will be analysed within SPSS. Missing data will be excluded from the analysis. Prior to running 
any analyses, all variables will be checked for outliers and homogeneity of variance. The primary aim 
of the analysis is to explore the relationship between variables of SC and functional outcomes.  
1. Demographics 
Initially, descriptive statistics will run on the data. This will also include t-tests and correlations 
(Pearson correlations if data is parametrically distributed and Spearman correlations if the data is non-
parametrically distributed) to identify any possible relationships between demographic information 
and cognitive or functional variables.  
2. Primary research question  
To explore the relationship between cognitive variables (e.g. measures of TOM and executive 
functioning) and functional outcomes, regression analyses will be used. Specifically, three regression 
models will be run, one for each of the outcome variables: psychological, social and interpersonal 
functioning. The predictor variables will be TOM, executive functioning and pre-morbid functioning.  
3. Secondary research questions  
T-test calculations and potentially and ANOVA will be completed to explore whether there are any 
differences between MS subtypes on cognitive variables. These results will be interpreted with 
caution, as they will have lower statistical power; however, this exploratory analysis will hopefully be 
able to inform of future research directions. 
Additionally, t-tests will be run to answer the second, secondary research question which explores 
whether there is a relationship between pre-morbid IQ and cognitive abilities. Specifically of interest 
is whether there is a relationship between pre-morbid IQ and TOM abilities. Detail the variables to be 
used for assessment and how these will be reported (e.g. means, standard deviations, medians etc.)  
 
Risks  
There is a medium likelihood of the test burden being too demanding on participants due to the 
testing session being too long/ taxing. However, the number/range of tests selected is required to 
adequately measure the constructs being explored through this study. In order to minimise the 
possible test burden, the neuropsychological tests selection was based on their suitability for use with 
individuals with MS, and those which have previously been used for research in this area. Additionally, 
participants will be offered a break within the session, or if required testing will be spread over 
multiple sessions to reduce the burden testing places on them.  
There is a low likelihood that participants may experiences high levels of psychological distress during 
testing. Participants will be informed in advance what will be involved in the study, and it may involve 
subject areas that they find distressing. The PI is experienced in supporting individuals who are 
experiencing high levels of psychological distress. Whilst there is a low likelihood of this occurring, the 
researcher will have contact details for unscheduled care assessment services, as well as other local 
support services. Participants will also have a five minute debrief at the end of the testing appointment 
where they can provide feedback on their testing experience and ask any questions. 
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As with any study using personal data, data-protection or confidentiality must be strongly considered. 
The likelihood of confidentiality being broken, or patient identifiable data being lost is very low. All 
paper documentation (e.g. neuropsychology record forms, questionnaires) will be transported from 
the appointment location to the physical rehabilitation psychology office in a locked bag. The paper 
records will remain there in a locked filing cabinet for the duration of the study. Data from the paper 
documents will be anonymised and entered into a spreadsheet which will be held in the secure NHS 
Fife drive. 
It is possible that test results may reveal more severe difficulties than was previously known. Prior to 
beginning teasing, potential participants will be made aware of the limits to confidentiality. If a case 
arises where the participants test results raise concern, this will be communicated to the participant 
and they will be informed that this information will be passed onto the most appropriate clinician 
involved in their case (e.g. their GP, neurologist) for them to consider and respond to. Confidentiality 
will not be broken without the participant being aware of the presence of concerns. 
 
Oversight Arrangements 
 Inspection of Records 
Investigators and institutions involved in the study will permit trial related monitoring and audits on 
behalf of the sponsor, REC review, and regulatory inspection(s).  In the event of audit or monitoring, 
the Investigator agrees to allow the representatives of the sponsor direct access to all study records 
and source documentation. In the event of regulatory inspection, the Investigator agrees to allow 
inspectors direct access to all study records and source documentation. 
 
Study Monitoring and Audit  
The ACCORD Sponsor Representative will assess the study to determine if an independent risk 
assessment is required.  If required, the independent risk assessment will be carried out by the 
ACCORD Quality Assurance Group to determine if an audit should be performed before/during/after 
the study and, if so, at what frequency. 
Risk assessment, if required, will determine if audit by the ACCORD QA group is required. Should audit 
be required, details will be captured in an audit plan. Audit of Investigator sites, study management 
activities and study collaborative units, facilities and 3rd parties may be performed. 
 
Good Clinical Practice  
Ethical Conduct 
The study will be conducted in accordance with the principles of the International Conference on 
Harmonisation Tripartite Guideline for Good Clinical Practice (ICH GCP). 
Before the study can commence, all required approvals will be obtained and any conditions of 




The Investigator is responsible for the overall conduct of the study at the site and compliance with the 
protocol and any protocol amendments.  In accordance with the principles of ICH GCP, the following 
areas listed in this section are also the responsibility of the Investigator.  Responsibilities may be 
delegated to an appropriate member of study site staff.   
Informed Consent 
The Investigator is responsible for ensuring informed consent is obtained before any protocol specific 
procedures are carried out. The decision of a participant to participate in clinical research is voluntary 
and should be based on a clear understanding of what is involved. 
Participants must receive adequate oral and written information – appropriate Participant 
Information and Informed Consent Forms will be provided. The oral explanation to the participant will 
be performed by the Investigator or qualified delegated person, and must cover all the elements 
specified in the Participant Information Sheet and Consent Form. 
The participant must be given every opportunity to clarify any points they do not understand and, if 
necessary, ask for more information. The participant must be given sufficient time to consider the 
information provided.  It should be emphasised that the participant may withdraw their consent to 
participate at any time without loss of benefits to which they otherwise would be entitled. 
The participant will be informed and agree to their medical records being inspected by regulatory 
authorities and representatives of the sponsor(s). 
The Investigator or delegated member of the trial team and the participant will sign and date the 
Informed Consent Form(s) to confirm that consent has been obtained. The participant will receive a 
copy of this document and a copy filed in the Investigator Site File (ISF). 
 
Study Site Staff 
The Investigator must be familiar with the protocol and the study requirements.  It is the Investigator’s 
responsibility to ensure that all staff assisting with the study are adequately informed about the 
protocol and their trial related duties. 
 
Data Recording 
The Principal Investigator is responsible for the quality of the data recorded in the CRF at each 
Investigator Site.  
 
 Investigator Documentation 
The Principal Investigator will ensure that the required documentation is available in local Investigator 
Site files ISFs.  
Confidentiality 
Participants’ personal data will be contained on the consent forms, record forms and questionnaires. 
These will be stored in a locked filing cabinet in the Psychology office of the NHS Fife Rehabilitation 
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Service. Access to the cabinet will require a key, which only the PI, field supervisor and two other 
psychologists within the team will have access too.   
Additionally, participants’ data will be stored anonymously on the secure network, using pseudonyms 
in place of personally identifiable data. In accordance with the Data Protection Act (2018), only data 
specifically required for this study will be recorded, it will be reviewed regularly during the study and 
after 5 years, and only kept for 10 years. A separate file, which links participants to the pseudonyms 
applied will be stored separately from the spreadsheet including patient data.  
The data collected in this study will only be used for the purposes of this study, to answer the research 
questions and will not be passed onto third parties, or be identifiable from the dissemination of the 
results. The Investigator and study site staff involved with this study may not disclose or use for any 
purpose other than performance of the study, any data, record, or other unpublished, confidential 
information disclosed to those individuals for the purpose of the study.  Prior written agreement from 
the sponsor or its designee must be obtained for the disclosure of any said confidential information 
to other parties. 
 
Data Protection 
All Investigators and study site staff involved with this study will comply with the requirements of the 
Data Protection Act 2018 with regard to the collection, storage, processing and disclosure of personal 
information and will uphold the Act’s core principles. Access to collated participant data will be 
restricted to individuals from the research team treating the participants, representatives of the 
sponsor(s) and representatives of regulatory authorities. 
Computers used to collate the data will have limited access measures via user names and passwords. 
Published results will not contain any personal data that could allow identification of individual 
participants. 
 
Study Conduct Responsibility 
 Protocol Amendments  
Any changes in research activity, except those necessary to remove an apparent, immediate hazard 
to the participant in the case of an urgent safety measure, must be reviewed and approved by the 
Chief Investigator.   
Amendments will be submitted to a sponsor representative for review and authorisation before being 
submitted in writing to the appropriate REC, and local R&D for approval prior to participants being 
enrolled into an amended protocol. 
 
 Management of Protocol Non-Compliance  
Prospective protocol deviations, i.e. protocol waivers, will not be approved by the sponsors and 
therefore will not be implemented, except where necessary to eliminate an immediate hazard to 
study participants. If this necessitates a subsequent protocol amendment, this should be submitted 
to the REC, and local R&D for review and approval if appropriate. 
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Protocol deviations will be recorded in a protocol deviation log and logs will be submitted to the 
sponsors every 3 months. Each protocol violation will be reported to the sponsor within 3 days of 
becoming aware of the violation.  All protocol deviation logs and violation forms should be emailed to 
QA@accord.scot 
Deviations and violations are non-compliance events discovered after the event has occurred.  
Deviation logs will be maintained for each site in multi-centre studies.  An alternative frequency of 
deviation log submission to the sponsors may be agreed in writing with the sponsors. 
  
Serious Breach Requirements 
A serious breach is a breach which is likely to effect to a significant degree: 
(a) the safety or physical or mental integrity of the participants of the trial; or 
(b) the scientific value of the trial. 
If a potential serious breach is identified by the Principal Investigator or delegates, the co-sponsors 
(seriousbreach@accord.scot) must be notified within 24 hours.  It is the responsibility of the co-
sponsors to assess the impact of the breach on the scientific value of the trial, to determine whether 
the incident constitutes a serious breach and report to research ethics committees as necessary.  
  
Study Record Retention  
Following completion of the study, the PI will remove all personal data within 6 months. As this is a 
student project, there will be a VIVA post completion, therefore, if additional changes are required 
the personal data will not already be removed. 
The anonymous research data will be stored for 3 years. The original paper record forms will be stored 
in a locked filing cabinet at the Physical Rehabilitation department, NHS Fife. Both the PI and field 
supervisor will have access to the raw data. The data will also be stored on an electronic file on the 
NHS Fife server, on a secure drive, owned by the PI. Should the PI leave the organisation, the dataset 
will be managed by the PI's field supervisor.  
When the retention period has elapsed, study documentation will not be destroyed without 
permission from the sponsor. 
 
 End of Study 
The end of study is defined as the last participant’s last visit.   
The Investigators or the co-sponsor(s) have the right at any time to terminate the study for clinical or 
administrative reasons.  
The end of the study will be reported to the REC, and R+D Office(s) and co-sponsors within 90 days, 
or 15 days if the study is terminated prematurely. The Investigators will inform participants of the 
premature study closure and ensure that the appropriate follow up is arranged for all participants 
involved. End of study notification will be reported to the co-sponsors via email to 
resgov@accord.scot.  




 Insurance and Indemnity  
The co-sponsors are responsible for ensuring proper provision has been made for insurance or 
indemnity to cover their liability and the liability of the Chief Investigator and staff. 
The following arrangements are in place to fulfil the co-sponsors' responsibilities: 
• The Protocol has been designed by the PI and researchers employed by the University and 
collaborators.  The University has insurance in place (which includes no-fault compensation) 
for negligent harm caused by poor protocol design by the Chief Investigator and researchers 
employed by the University. 
• Sites participating in the study will be liable for clinical negligence and other negligent harm 
to individuals taking part in the study and covered by the duty of care owed to them by the 
sites concerned.  The co-sponsors require individual sites participating in the study to arrange 
for their own insurance or indemnity in respect of these liabilities. 
• Sites which are part of the United Kingdom's National Health Service will have the benefit of 
NHS Indemnity. 
 
 Reporting, Publications and Notifications of Results  
When recruited into the study, individuals will be asked whether or not they wish to be informed of 
the findings upon completion. Participants who opt into this will be sent a written summary of the 
research findings. Any staff, families and third sector organisations who take part in the study will also 
be offered information on the study results. 
 
In NHS Fife there is a bi-annual research conference run by the psychology department. The results of 
this study will be disseminated there. Additionally, the findings will be presented to the 
neuropsychology service as part of their regular in-service educational programme.  
 
It is hoped that this study will be published in a relevant peer-reviewed neuropsychology journal (e.g. 
the Journal of the International Neuropsychological Society, Neuropsychology), and relevant 
conferences post completion. No personal identifiable data will be included in publications or 
presentations.  
Authorship Policy  
Ownership of the data arising from this study resides with the study team.   
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Dear Dr Calia  
 
Study title: Psychological, Interpersonal and Social Functioning in 
Multiple Sclerosis: The Role of Theory of Mind 
REC reference: 19/SS/0006 
Protocol number: CAHSS1809/0 
IRAS project ID: 250096 
 
Thank you for your letter of 10 February 2019 , e di g  he C i ee s request for further 
information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair.  
 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the date of 
this opinion letter.  Should you wish to provide a substitute contact point, require further 
information, or wish to make a request to postpone publication, please contact 
hra.studyregistration@nhs.net outlining the reasons for your request. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation as 
revised, subject to the conditions specified below. 
 
 
Conditions of the favourable opinion 
 












Management permission must be obtained from each host organisation prior to the start of the 
study at the site concerned. 
 
Management permission should be sought from all NHS organisations involved in the study in 
accordance with NHS research governance arrangements. Each NHS organisation must confirm 
through the signing of agreements and/or other documents that it has given permission for the 
research to proceed (except where explicitly specified otherwise).  
Guidance on applying for HRA and HCRW Approval (England and Wales)/ NHS permission for 
research is available in the Integrated Research Application System, at www.hra.nhs.uk or at 
http://www.rdforum.nhs.uk.  
 
Where a NHS ga i a i  e i  he d  i  i i ed  ide if i g a d efe i g e ia  
participants to research sites ("participant identification centre"), guidance should be sought from 
the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation.  
 
Sponsors are not required to notify the Committee of management permissions from host 
organisations 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered on 
a publically accessible database within 6 weeks of recruitment of the first participant (for medical 
device studies, within the timeline determined by the current registration and publication trees).   
 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g. when submitting an amendment.  We will audit the registration details as part of 
the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered but for 
non-clinical trials this is not currently mandatory. 
 
If a sponsor wishes to request a deferral for study registration within the required timeframe, they 
should contact hra.studyregistration@nhs.net. The expectation is that all clinical trials will be 
registered, however, in exceptional circumstances non registration may be permissible with prior 
agreement from the HRA. Guidance on where to register is provided on the HRA website.   
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable). 
 




The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see 












The final list of documents reviewed and approved by the Committee is as follows: 
 
Document   Version   Date   
Covering letter on headed paper [Covering letter following REC 
review ]  
1  10 February 2019  
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Professional indemnity confirmation ]  
  31 July 2018  
GP/consultant information sheets or letters [GP Letter]  2  16 January 2019  
IRAS Application Form [IRAS_Form_05122018]    05 December 2018  
Letters of invitation to participant [Letter of invitation]  2  23 January 2019  
Letters of invitation to participant [Letter of invitation- NHS Lothian]  1  10 February 2019  
Letters of invitation to participant [Letter of invitation- significant 
other ]  
2  23 January 2019  
Participant consent form [Participant consent form ]  2  23 January 2019  
Participant information sheet (PIS) [Participant Information Sheet]  2  23 January 2019  
Participant information sheet (PIS) [Participant information sheet for 
significant other]  
2  23 January 2019  
Research protocol or project proposal [Study Protocol]  2  10 February 2019  
Summary CV for Chief Investigator (CI) [CI CV]  1  13 October 2018  
Summary CV for student [Student CV]  1  11 October 2018  
Summary CV for supervisor (student research) [Emily Newman CV]  1  12 October 2018  
Summary of any applicable exclusions to sponsor insurance (non-
NHS sponsors only) [Clinical Trail Liability]  
1  31 July 2018  
Summary of any applicable exclusions to sponsor insurance (non-
NHS sponsors only) [Employers liability insurance]  
1  01 August 2018  
Summary of any applicable exclusions to sponsor insurance (non-
NHS sponsors only) [Policy confirmation]  
1  24 July 2018  
Summary of any applicable exclusions to sponsor insurance (non-
NHS sponsors only) [Professional Indemnity Confirmation]  
1  31 July 2018  
Validated questionnaire [DEX Informant form]      
Validated questionnaire [DEX Self rater form]      
Validated questionnaire [MSQOL-54 form]      
Validated questionnaire [Revised Dyadic Adjustment Scale]      
Validated questionnaire [Social functioning scale]      
Validated questionnaire [BDI]      
Validated questionnaire [Brixton Test]  1  13 December 2018  
Validated questionnaire [Hayling Test]  1  13 December 2018  
Validated questionnaire [Verbal Fluency Test]  1  13 December 2018  
Validated questionnaire [Test of Premorbid Function Test]  1  13 December 2018  
Validated questionnaire [Reading the Mind in the Eyes Test]  1  12 April 2018  









Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees and complies fully with the Standard Operating Procedures for Research Ethics 
Committees in the UK. 
 




The attached document Af e  e ca  e e   g da ce f  e ea c e  gives detailed guidance 
on reporting requirements for studies with a favourable opinion, including: 
 
x Notifying substantial amendments 
x Adding new sites and investigators 
x Notification of serious breaches of the protocol 
x Progress and safety reports 
x Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of changes 




The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received and 
the application procedure. If you wish to make your views known please use the feedback form 




We are pleased to welcome researchers and R&D staff at our training days  see details at 
http://www.hra.nhs.uk/hra-training/   
 
19/SS/0006                          Please quote this number on all correspondence 
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Appendix H: Participant Information Sheet  
 
                                                                                 
(*This NHS logo will be changed 
for each recruitment site*)  
University of Edinburgh 
School of Health in Social Science 




Participant Information Sheet: Significant Other 
 
Psychological, Interpersonal and Social Functioning in Multiple Sclerosis:  





You are being invited to participate in a research study.  Before you decide whether you 
would like to take part we would like you to understand the purpose of this study and what 
your participation would involve. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part. 
 
What is the purpose of the study? 
 
Theory of mind refers to an individual’s ability to understand that other people have their 
own thoughts/ opinions/ beliefs which can differ from our own. Theory of mind is important 
in social interactions as it allows us to adapt our behaviour and know what information to 
communicate to others, building on what they already know. Our research wants to find out 
if an individual’s theory of mind abilities impact upon their mood, relationship quality and 
social engagement in individuals with Multiple Sclerosis (MS). 
 
Why have I been invited?  
 
Our study will be recruiting individuals with a diagnosis of MS, who are known to the NHS 
Fife Rehabilitation Service/ NHS Lothian Anne Rowling Clinic (delete as appropriate). As your 
partner/ family member/ friend (delete as appropriate) has previously been, or are currently 
being seen within this service they were invited to participate. As part of their involvement 








Do I have to take part? 
 
No, you do not have to take part. If you decide to take part you are still free to withdraw at 
any time and without giving a reason. Your participation is voluntary.  
 
What will I have to do? 
 
Taking part would involve you being asked to complete a few questionnaires (which are 
enclosed here) at home, which ask about your partner’s/ family member’s/ friend’s (delete 
as appropriate) relationships, behaviours and social activities. These will take around 30 
minutes to complete. Full details on how to complete the questionnaires are included and 
attached to the front of the questionnaire booklet. 
 
If you wish to take part after reading this information sheet, please complete the enclosed 
questionnaires and return them in the stamped addressed envelope provided.  
 
What are the possible disadvantages or risks of taking part?  
 
There are few risk or disadvantages associated with taking part and you will be able to 
withdraw from the study at any time, without specifying a reason.  
 
It is possible that sensitive topics could arise when completing the questionnaires, which 
you may find distressing. If you have any concerns about the material or find completing the 
questionnaires distressing, you can contact Rachel Gibson (Principle Investigator) on 01383 
562 402 to discuss these further.  
 
Finally, it is possible that the pattern of task results may cause the research team to be 
concerned about your partner/ family member/ friend (delete as appropriate). Whilst the 
likelihood of this is low, if the research team were to have any concerns, this would be 
discussed with your partner/ family member/ friend (delete as appropriate). Information 
would also be passed onto their GP who will be able to discuss the concerns with them. 
Otherwise, we are unable to provide individual feedback.   
 
What are the possible benefits of taking part?  
 
It is hoped that eventually this research will help us to better understand the impact of 
theory of mind abilities on daily functioning in individuals with MS. It is hoped that this will 
inform future research studies, which in turn may enhance treatments and case 
management.  
 
Will my participation be kept confidential?  
 
All information which is collected from you about your partner/ family member/ friend 
(delete as appropriate) during the course of the research will be kept strictly confidential. 
Their identifiable data will be kept and stored securely within the NHS on a secure drive, 
which only the research team will have access to.  Identifiable data will be stored separately 
from the data used in the data analysis. Your partner/ family member/ friend (delete as 
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appropriate) will be given a unique participant number, which only the research team will 
have access to.  
 
In addition, data collected during the study may be looked at by individuals from the 
Sponsor (the University of Edinburgh) or from the NHS organisations, where it is relevant to 
your taking part in this research. 
 
You can find out more about how we use your information and our legal basis for doing so 
in our Privacy Notice at: https://www.ed.ac.uk/records-management/privacy-notice-
research and https://www.nhsfife.org/nhs/index.cfm (and clicking on the “Data Protection 
Notice” tab at the bottom of the page). 
 
For further information on the use of personal data by NHS sites, please link to the Health 
Research Authority (HRA) website: https://www.hra.nhs.uk/information-about-patients/  
 
What if I want to stop the study?  
 
Whether you take part is up to you and your decision, and your partner/ family member/ 
friend (delete as appropriate) will still be able to participate.  You may change your mind 
about being in the study and withdraw from the study at any time.  
 
What will happen to the results of the study? 
 
The results of this study will be reported as part of a doctorate student thesis project but no 
names will be included and it will not be possible for you to be identified.   
 
We hope that the results of this study will be published in a scientific journal or presented at 
a conference, but again no names will be included and it will not be possible for you to be 
identified. 
 
Your partner/ family member/ friend (delete as appropriate) has been asked whether they 
wish to be provided with a summary of the research findings upon completion of the study. 
If they have requested to be provided with a written summary, this will be posted to them 
upon completion.  
 
Who has reviewed the study? 
 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee. A favourable ethical opinion has been obtained from SESREC01. NHS 
management approval has also been obtained 
 
What if I have further questions? 
 
Thank you for taking the time to hear about our study. We would be really pleased to talk to 
you about it some more if you have any questions. If you have any further questions about 




If you would like to discuss this study with someone independent of the study team please 
contact:  Susan McKenzie (Consultant Clinical Psychologist, NHS Fife) on: 01592 226 767. 
 
What if there is a problem?  
 
If you wish to make a complaint about the study please contact NHS Fife: 
 
Patient Relations Department 






Phone: 01592 648 153 
Email: patientrelations.fife@nhs.net 
 
If you wish to raise a complaint on how we have handled your personal data, you can contact 
our Data Protection Officer who will investigate the matter. If you are not satisfied with our 
response or believe we are processing your personal data in a way that is not lawful you can 
complain to the Information Commissioner’s Office (ICO) at https://ico.org.uk/.  
Data Protection Officer contact information:  
University of Edinburgh  
Data Protection Officer  
Governance and Strategic Planning  
University of Edinburgh  
Old College  
Edinburgh  
EH8 9YL  






Appendix I: Consent Form 
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recruitment site*)  
       
University of Edinburgh 
School of Health in Social Science 




Participant Consent Form 
CONSENT TO PARTICIPATE IN A RESEARCH STUDY 
V2 23/01/2019: 
 
Participant identification ID 
 
Study: Psychological, Interpersonal and Social Functioning in Multiple Sclerosis: The Role 
of  Theory of Mind 
 
Investigator: Rachel Gibson (Trainee Clinical Psychologist, University of Edinburgh) 
 Please initial box 
1. I confirm that I have read and understand the information sheet (V2, 23/01/2019) for the 
above study and have had the opportunity to consider the information and ask questions.*  
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected.* 
 
3. I understand that relevant sections of my medical notes and data collected during the study 
may be looked at by individuals from the regulatory authorities and from the Sponsor(s) 
(the University of Edinburgh) or from the NHS Board(s) where it is relevant to my taking 
part in this research. I give permission for those individuals to have access to my records.* 
 
4. I agree to my GP being informed of my participation in this study.* 
  
5. I agree to take part in the above study.* 
 
6.  I wish to be informed of the study findings upon completion.  
 
 
______________________ ________________ ________________ 
Name of Participant  Date Signature 
 
_________________________ ________________ ________________ 
Name of Person taking consent Date  Signature 
 
* Mandatory fields 
Original (x1) to be retained in site file.  Copy (x1) to be included in patient notes.  Copy (x1) to 
be retained by the participant. 
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